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2. Abstract 
 
 
Background 
 Recent findings indicate a regulatory role of microglia on neurogenesis in the 
subventricular zone (SVZ). SVZ microglia in the adult rat are sought to adopt a supportive 
phenotype after ischemic stroke. Early postnatal microglia are endogenously activated and may 
therefore express an increased sensitivity to neonatal hypoxia-ischemia (HI). Therefore, we 
sought to investigate the impact of HI on the microglial phenotype in the early postnatal SVZ. 
 
Methods 
 Postnatal-day (P)7 rats underwent sham or right-hemispheric HI surgery. Microglia in 
the SVZ, the adjacent cortex and the corpus callosum were immunohistochemically analyzed at 
P10, P20 and P40. Further, the transcriptome of SVZ microglia isolated at P10 and P20 was 
analyzed. Lastly, the effect of P10 microglia on in vitro neurosphere generation was 
investigated. 
 
Results 
 The SVZ microglial response upon HI, characterized by cellular accumulation, 
prolonged activation and phagocytosis, is SVZ-specific and does not occur in adjacent brain 
regions. At the transcriptomic level, SVZ microglia adopt a complex phenotype, that resembles 
neither the M1 or M2 polarization state, but instead shares commonly expressed genes with 
microglia in neurodegenerative diseases. Finally, SVZ microglia appear to show trophic support 
for neurosphere generation in vitro in a concentration dependent manner.  
 
Conclusions 
 Microglia are an inherent cellular component of the early postnatal SVZ and undergo 
specific developmental changes that are disrupted by neonatal HI injury. The SVZ microglial 
response to HI is complex and beyond a simplified pro- or anti-inflammatory phenotype. Our 
findings represent a solid basis for future research on SVZ microglia.  
   3. Introduction 
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3. Introduction 
 
 
3.1. Clinical perspective on neonatal HI 
 
 Neonatal encephalopathy is a clinically defined syndrome of disorders of 
neonatal brain function. It has an estimated incidence of 3 per 1000 live birth. 
However, neonatal encephalopathy is still missing an universally accepted 
definition because its etiologies are numerous and the clinical manifestation 
highly depends on the maturation stage of the newborn (Kurinczuk et al., 2010). 
 Hypoxic-ischemic encephalopathy (HIE) represents a sub-category of 
neonatal encephalopathy. HIE has an estimated incidence of 1.5 per 1000 live 
births and is by definition caused by intrapartum asphyxia (Kurinczuk et al., 
2010). It accounts for 25 % of developmental disabilities in children (Shevell et 
al., 2000) and is one of the most common causes of morbidity and mortality in 
term and preterm neonates, accounting for 23 % of neonatal deaths worldwide 
(Lawn et al., 2005). Patients with HIE typically present with one of two injury 
patterns: i) the basal ganglia-thalamus pattern with injuries affecting the deep 
gray nuclei and perirolandic cortex or ii) the watershed predominant pattern with 
injuries localized in the white matter and cortex within the vascular cerebral 
watershed zones (i.e. the border zones between the vascular territory of the 
anterior and middle cerebral artery, or between the middle and posterior 
cerebral artery, respectively). Patients with the basal ganglia-thalamus pattern 
most commonly suffer from cerebral palsy, dysarthria, visual impairment and 
epilepsy, whereas patients with the watershed predominant pattern are 
prominently affected by cognitive impairment and epilepsy (Pimentel-Coelho et 
al., 2012). 
 The development of HIE can be divided into three consecutive phases: 
The first phase is characterized by an acute energy depletion in hypoxic brain 
cells and subsequent apoptosis and necrosis. The second phase is dominated 
by successive brain injuries which are caused by excitotoxicity (excessive 
extracellular accumulation of glutamate), mitochondrial breakdown, reactive 
oxygen / nitrogen species, and an inflammatory reaction by the immune system. 
   3. Introduction 
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A third phase, defined by a chronic inflammatory state, is suggested to worsen 
outcome, predispose to further injury, or reduce repair and regeneration (Fleiss 
and Gressens, 2012). 
 Up to date, the only established therapeutic intervention for HIE is 
hypothermia, a relatively unspecific neuroprotective treatment, which attenuates 
the second phase of HIE. If started within 6 hours after birth, hypothermia 
successfully reduces morbidity and mortality among patients with HIE 
(Shankaran et al., 2012). Further, various neuroprotective (e.g. administration of 
erythropoietin) or neuroregenerative strategies (e.g. administration of 
mesenchymal stem cells or neurotrophic molecules) are evaluated in clinical 
trials (Pimentel-Coelho et al., 2012). 
 In the reaction following HIE, microglia were considered to be the main 
inflammatory amplifier and thus promoting damage (Khwaja and Volpe, 2008; 
Kaur et al. 2013). However, recent studies underscore the complex response of 
microglia to injury, which includes also neuroprotective and neuroregenerative 
features (Alvarez-Díaz et al., 2007; Hagberg et al., 2015). 
 
 
3.2 The Rice-Vannucci model of HI to study ischemia-induced 
neurogenesis in the postnatal SVZ 
 
 In basic research, the term neonatal hypoxia-ischemia (HI) is often used 
as a synonym for HIE, although clear definitions of HI are pending. Several 
animal models of neonatal HI have been developed. Among them, the Rice-
Vannucci model, first described in 1981 by Rice and colleagues, is the most 
commonly used. In brief, the right common carotid artery (CAA) in a 7-day old 
Sprague-Dawley rat is permanently ligated, followed by exposure of the animal 
to an 8 % oxygen / 92 % nitrogen gas mixture for 3.5 h at 37 °C. This procedure 
reproduces features of HIE, such as striatal and cortical damage as well as 
subcortical and periventricular white matter injury in the brain hemisphere 
ipsilateral to the CAA ligation. The 7-day old rat brain is thought to reflect the 
late gestational conditions in the human brain. A major disadvantage of this 
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model is the extensive variability of injury size among individuals, despite close 
adherence to procedure protocols (Fig. 1). Adaptation to other rat strains and 
mice as well as adjustments to individual laboratory settings resulted in various 
modifications of the original Rice-Vannucci model, but the essential combination 
of CAA occlusion, followed by exposure to hypoxia, remained (Ngyuen et al., 
2015). 
 
 
Figure 1: Representative cresyl violet stainings of brain sections from 10-day old rats that 
underwent sham or HI surgery 3 days before. The degree of HI injury demonstrates a marked 
variability among different animals (modified, from C. Brégère). 
 
 The Rice-Vannucci model and its modifications do not only enable to 
study the pathological features of HI injury, but also endogenous regenerative 
processes of the neonatal brain, specifically ischemia-induced neurogenesis in 
the subventricular zone (SVZ). The SVZ is a cellularly dense structure 
surrounding the lateral ventricles and contains a population of neural stem cells 
(NSC). In the postnatal rodent SVZ, NSC continuously give rise to neural 
progenitor cells (NPC) which migrate along the rostral migratory stream to the 
olfactory bulb, where they differentiate into interneurons (Zhang et al., 2008). 
Studies in the adult rodent demonstrated that acute ischemic stroke induces 
SVZ enlargement and NPC proliferation with consecutive migration of NPC from 
the SVZ towards the ischemic lesion (Arvidsson et al., 2002; Parent et al., 2002; 
Thored et al., 2006). Hence, studies in models of neonatal HI injury in mice 
(Plane et al., 2004) and rats (Ong et al., 2005, Yang & Levison, 2006) confirmed 
that the identical processes of SVZ enlargement, increased NPC proliferation 
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and migration towards the injury also occur after neonatal HI. 
 Thus, ischemia-induced neurogenesis - the enhanced NPC proliferation 
and migration from the SVZ - is considered a promising target for therapeutic 
strategies to improve recovery after brain injury. 
 
 
3.3. The role of microglia in brain development and postnatal 
neurogenesis 
 
 
3.3.1. Microglial origin and maintenance 
 
 Microglia are the resident tissue macrophage of the central nervous 
system (CNS) and essential to maintain homeostasis in health and to initiate 
immune responses in disease. They belong to the 4 most common cell types 
present in the brain, the others being neurons, astrocytes and oligodendrocytes. 
Although microglia together with astrocytes and oligodendrocytes are 
collectively called neuroglia (or simply glia), microglia do not derive from the 
neuroectoderm and migrate to the CNS during early embryogenesis (Ginhoux et 
al., 2010).  
 Microglia are distributed throughout the adult brain and spinal cord and 
represent about 10 % of the non-neuronal cell population with prominent 
regional differences in both the rodent (Lawson et al., 1990) and human brain 
(Mittelbronn et al., 2001).  
 
 Although microglia had already been described earlier as "pathological 
cells" in various brain diseases by Karl Frommann, Franz Nissl, Alois Alzheimer 
and others, a silver carbonate impregnation staining modified by del Rio-
Hortega (1882 - 1945) represented a break-through in their identification as a 
unique cell type (del Rio-Hortega, 1932). Del Rio-Hortega's studies between 
1919 and 1927 were the basis for his landmark publication "Microglia" in 1932. 
In this article, del Rio-Hortega did not only introduce microglia as a distinct cell 
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type in the CNS, he also presented several fundamental postulates on microglia 
that were visionary at that time (del Rio-Hortega, 1932). In summary, he 
described microglia as amoeboid-shaped cells of mesodermal origin, which 
populate the CNS during early development and while the brain matures, adopt 
a tree-like ramified morphology. Upon pathological events, microglia react by 
acquiring a phenotype reminiscent to the early developmental stage, which is 
characterized by cellular proliferation, migration to the site of damage and 
phagocytosis (Kettenmann et al. 2011). Remarkably, these hypotheses, 
introduced almost a century ago, have all been confirmed and remain current. 
Among them, the microglial origin was the subject of most debate. 
 Pio del Rio-Hortega, together with Santiago Ramon y Cajal and William 
Ford Robertson, already suspected that microglia are of mesodermal origin, 
although their assumptions were largely ignored by the scientific community. 
Instead, the majority agreed for decades that microglia derive from the neuro-
ectoderm. Nevertheless, del Rio-Hortega's original hypothesis gained popularity 
through major discoveries such as phenotypic homologies between microglia 
and macrophages (Perry et al., 1985) and microglial necessity for PU.1, an 
essential transcription factor for myeloid cell production (McKercher et al., 
1996). Although the myeloid origin of microglia became accepted, it was still 
unknown how these cells populate the CNS. For a long time, microglia were 
thought to derive from bone marrow (BM)-derived circulating blood monocytes 
and to be continuously replaced throughout life. However, immunohistochemical 
(IHC) studies in the fetus showed that myeloid cells invade the brain as early as 
on embryonic day (E) 8.5 in rodents (Alliot et al., 1999) and 4.5 weeks of 
gestation in humans (Monier et al., 2007), which is at a time before BM 
hematopoiesis begins. Indeed, fate-mapping studies revealed that microglia 
actually derive from primitive myeloid progenitors in the yolk sac before E8 
(Ginhoux et al., 2010) that migrate to the developing brain before the blood 
brain barrier (BBB) establishes. Furthermore, the transcription factor Myb was 
found to be required for the development of hematopoietic stem cells from 
E10.5 on, but not for the primitive hematopoiesis in the yolk sac. Accordingly, 
mice lacking Myb developed normal microglia but not BM-derived monocytes 
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(Schulz et al., 2012). Thus, microglia and BM-derived monocytes represent two 
different myeloid cell populations. 
 
 However, the question remained if monocytes may still contribute to a 
certain extent to the microglial pool after birth. Indeed, earlier studies using BM 
chimeras suggested that BM-derived stem cells can invade the CNS after 
whole-body irradiation and adopt a microglia-like phenotype (Priller et al., 2001). 
However, whole-body radiation was found to impair the BBB which potentially 
confounded these results. In consequence, studies that did not damage the 
BBB by avoiding irradiation of the head (Mildner et al., 2007) or by combining 
parabiosis with myeloablation (Ajami et al., 2007; 2011) did not show long-term 
contribution of infiltrating monocytes to the microglial pool. 
 Recently, an elegant genetical system was developed for microglial 
depletion without the need for myeloablation. Briefly, a mouse line, in which 
tamoxifen-inducible Cre-recombinase is expressed under the control of the 
fractalkine receptor (CX3CR1) promotor, was crossed with a Cre-inducible 
diphtheria toxin receptor (iDTR) mouse line. In these CX3CR1CreER:iDTR mice, 
tamoxifen injections induced diphtheria toxin receptor expression specifically in 
CX3CR1+ microglia, which were subsequently depleted by diphtheria toxin 
administration. After conditional depletion, CNS-resident microglia, but not 
peripheral monocytes, repopulated the brain within 5 days by extensive 
proliferation involving interleukin (IL)-1 receptor signaling (Bruttger et al., 2015). 
Thus, microglia populate the CNS during early embryogenesis as a distinct 
group of myeloid cells and maintain the capacity for self-renewal under 
physiological conditions without involvement of BM-derived progenitor cells. 
 Certain CNS inflammatory conditions accompanied with massive BBB 
breakdown, such as ischemic stroke, recruit monocytes to the site of injury 
where they transform to tissue macrophages. However, little is still known about 
the long-term fate of these tissue macrophages and if they become integrated in 
the microglial network or are only a temporary addition. Attempts to address 
these questions are hampered by the fact that tissue macrophages and 
microglia could hitherto not be distinguished by IHC stainings. Recent findings 
in CX3CR1GFP/+CCR2RFP/+ BM-chimeric mice (with unaltered CX3CR1+/+ 
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microglia) undergoing ischemic stroke demonstrated a restricted perilesional 
presence of CX3CR1GFP/+ tissue macrophages until 28 days after the injury 
(Garcia-Bonilla et al., 2016), indicating that tissue macrophages persist in the 
CNS for at least one month after ischemia. 
 
 
3.3.2. Microglia in the developing CNS 
 
 Historically, microglia were known as mediators of inflammation. 
Consequently, ramified microglia in the healthy adult brain were thought to 
reflect a stable "resting-quiescent" phenotype and become activated only under 
pathological circumstances. In a pivotal study using in vivo two-photon 
microscopy, Nimmerjahn and colleagues (2005) demonstrated that ramified 
microglia are actually highly dynamic by constant extension and retraction of 
their cellular processes and hereby physically interact with their neighbouring 
cells. This unexpected finding gave rise to a series of fascinating discoveries on 
the sculpturing role of microglia in the healthy brain, especially during CNS 
development. On the other hand, these findings also pointed out how critically 
dependent brain development is on properly functioning microglia. 
 
 Microglia colonize the developing brain as early as E8.5 (Ginhoux et al., 
2010), before the CNS will undergo extensive developmental changes. The 
early presence of microglia in the developing brain raised the question if 
microglia participate in neurodevelopment. A prominent feature of early CNS 
development is selection of redundant newborn cells through programmed cell 
death (Burek and Oppenheim, 1996). Indeed, microglia are a key player 
involved in this process by inducing apoptosis and subsequently phagocytosing 
neuronal cells (Ferrer et al., 1990; Marin-Teva et al., 2004; Wakselman et al., 
2008) via Triggering receptor expressed on myeloid cells 2 (TREM-2) / TYRO 
protein tyrosine kinase-binding protein (DAP12) signaling without eliciting 
inflammation (Takahashi et al., 2005). During the late stages of cortical 
neurogenesis, microglia specifically accumulate in the embryonic SVZ and 
phagocytose NPCs, thus actively regulating the number of NPCs in the 
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developing brain (Cunningham et al., 2013). In addition, observations in vitro 
where microglia contacted previously live NPCs and subsequently engulfed 
them (Fricker et al., 2012; Cunningham et al., 2013) led to the hypothesis that 
microglia may even phagocytose live cells, although the direct evidence is still 
pending (Brown and Neher, 2014). 
 
 Microglia are not only executors of programmed cell death, but are 
equally important for survival, proliferation and differentiation of NPCs via 
release of trophic factors such as low concentrated cytokines, including IL-1β, 
IL-6, tumor necrosis factor alpha (TNF-ɑ) and interferon gamma (IFN-γ) 
(Shigemoto-Mogami et al., 2014) or insulin-like growth factor 1 (IGF-1) (Ueno et 
al., 2013). IGF-1 is a well known neurotrophic factor and affects NPCs in 
multiple ways, including anti-apoptotic effects (Chrysis et al., 2001), and 
reduces cell cycle length and increasing cell cycle reentry (Hodge et al., 2004). 
The microglial support of developmental neurogenesis is addressed in more 
detail in chapter "3.3.3. Microglial and neurogenesis". 
 
 In addition to regulation of newborn cell fate, microglia play a substantial 
role in establishing connectivity in the developing brain through controlled 
elimination of unnecessary synapses. Similar to the programmed cell death of 
surplus cells, synaptic connections are initially produced in excess, followed by 
removal of redundant or faulty synapses called 'synaptic pruning'. Microglia are 
temporarily enriched in brain regions undergoing synaptic refinement and 
contact synapses in a neuronal activity-depending manner (Wake et al., 2009; 
Tremblay et al., 2010; Schafer et al., 2012). Weak synapses are identified and 
eventually removed either via interaction of synaptic complement C1q and C3 
and microglial complement receptor 3 (CR3) (Schafer et al., 2012) or via 
interaction of neuronal fractalkine (CX3CL1) with microglial CX3CR1 (Paolicelli 
et al., 2011). Perturbing the synaptic pruning has long-lasting consequences on 
development. Knock-out of several microglial signaling proteins (CX3CR1, CR3, 
DAP12) or depleting microglia with colony stimulating factor 1 receptor (CSF1R) 
antibodies significantly alters the outgrowth of dopaminergic axons in 
the forebrain and the laminar positioning of subsets of neocortical interneurons 
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(Squarzoni et al., 2014). Further, conditional depletion of microglia in 
CX3CR1CreER:iDTR one-month old mice causes deficits in multiple learning 
tasks and learning-induced synaptic remodelling (Parkhust et al., 2013).  
 
 Lately, the different stages of microglial developmental have been 
extensively characterized using genome-wide expression profiling (Matcovitch-
Natan et al., 2016). Murine microglia were isolated from 9 time points, in utero 
from E10.5 until E16.5, early postnatally from postnatal day (P)3 until P9 and 
from the two-months old adult mouse. Global gene expression analysis 
revealed 3 distinct developmental stages (E10.5 - E14, E19 - P9, >P9), which 
are characterized by different regulatory factors (Matcovitch-Natan et al., 2016). 
In line with these results, another study identified transmembrane protein 119 
(TMEM119) as a novel marker for adult microglia (Bennett et al., 2016). 
TMEM119 expression is developmentally regulated and reaches adult levels 
after P14. Thus, microglia in the early postnatal brain are yet not fully maturated 
and may therefore differentially react to injury compared to their adult 
counterparts. 
 Of note, these two recent studies analyzed early postnatal microglia on a 
whole-brain scale. However, earlier studies already noticed marked regional 
differences in microglia within the first two weeks after birth. Fascinatingly, it 
was once more del Rio-Hortega who described first a distinctive accumulation of 
amoeboid-shaped microglia restricted to the SVZ and supraventricular corpus 
callosum while cortical microglia already display a ramified morphology (del Rio-
Hortega, 1932). Successive histological analyses characterized these amoeboid 
microglia as highly proliferative and phagocytic (Wu et al., 1992; Hristova et al., 
2010). Importantly, in a study by Shigemoto-Mogami et al. (2014), these early 
postnatal SVZ microglia were shown to be highly activated (defined by their 
expression of the lysosomal marker CD68), and to enhance the proliferation of 
NPCs in the SVZ. 
 
 In conclusion, microglia are substantially involved in neurodevelopment 
as soon as they migrate to the brain. Concurrent to brain development, 
microglia undergo a step-wise maturation process themselves. Recent genome-
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wide expression analyses demonstrated that murine microglia retain a 
developmental phenotype until the end of the second postnatal week. In 
particular, microglia in the SVZ are highly activated and support NPC 
proliferation during that early postnatal time period.  
 
 
3.3.3. Microglia and neurogenesis 
 
 In the healthy mammal brain, the major neurogenic stem cell niches are 
the subgranular zone (SGZ) in the hippocampus and the SVZ next to the lateral 
ventricles. 
 The SGZ is a thin layer of cells, including NSCs / NPCs, forming one of 
several components of the dentate gyrus in the hippocampus. Throughout life, 
SGZ-derived NPCs migrate locally into the granular region of the dentate gyrus 
to differentiate into neuronal granule cells. These granule cells become then 
integrated in the hippocampal network, which is crucial for learning and memory 
functions. In brief, type-1 radial glial-like stem cells give rise to type-2 progenitor 
cells through asymmetrical cell division. Type-2 progenitor cells are highly 
proliferative and expand in numbers while eventually transforming into type-3 
cells which will then exit the cell-cycle and differentiate into excitatory granule 
neurons that will locally integrate into the granular layer of the dentate gyrus 
(Kempermann et al., 2015). 
 The other prominent stem cell niche is the SVZ, which lines out the walls 
of the lateral ventricles. In contrast to neurogenesis in the SGZ, SVZ-derived 
neurons migrate extensively along the rostral migratory stream and differentiate 
into interneurons in the olfactory bulb. While the rostral migratory stream in 
rodents is characterized in great detail, its existence in humans is controversial. 
Within the SVZ, astrocyte-like type-B cells are the quiescent stem cells which 
generate transient amplifying type-C cells by asymmetric division. Type-C cells 
proliferate and give rise to the type-A NPCs which then migrate and differentiate 
to become neurons (Zhang et al., 2008). 
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 Microglia are an inherent cellular component of the neurogenic niches 
(Sato, 2015). While originally, microglia as mediators of inflammation were 
thought to negatively influence neurogenesis, more recent studies brought 
evidence that in the healthy brain, they support neurogenesis and neuronal 
survival by secreted cytokines and trophic factors. However, the potentially 
versatile roles of microglia in the neurogenic niches after brain injury are still 
widely unknown. 
 
 Earlier studies about the microglial role on SGZ neurogenesis 
demonstrated that lipopolysaccharide (LPS)-induced acute inflammation 
reduces neurogenesis in the adult rat hippocampus by microglial secretion of IL-
6 and TNF-ɑ (Monje et al., 2003; Ekdahl et al., 2003). Additional studies 
underlined that microglial release of interleukins, including IL-1β reduce 
hippocampal neurogenesis in the aged rat, also without prior exposure to LPS 
(Gemma et al., 2007). On the other hand, hippocampal microglia were also 
shown to be neurotrophic in the context of different models of induced 
neurogenesis, including enriched environment housing, wheel running, status 
epilepticus or adrenalectomy (Williamson et al., 2012; Kohman et al., 2012; 
Gebara et al., 2013; Vukovic et al., 2012; Choi et al., 2008). Adult rats, exposed 
to an enriched environment, upregulate microglial ionized calcium-binding 
adapter molecule 1 (Iba1) expression and brain-derived neurotrophic factor 
(BDNF) in the hippocampus and specifically in the dentate gyrus. Interestingly, 
when exposed to LPS, these animals express an attenuated IL-1β and TNF-ɑ 
response in the hippocampus than control animals (Williamson et al., 2012). An 
alternative model to induce hippocampal neurogenesis is wheel running. While 
wheel running induces proliferation of SGZ NPCs, it concurrently reduces the 
total number of SGZ microglia. However, the relative proportion of supportive 
IGF-1+ microglia actually increases (Kohman et al., 2012; Gebara et al., 2013). 
In contrast to these findings, another study did not find a decrease of 
hippocampal microglia after running, but also demonstrated increased 
neurogenesis in vitro which was mediated by SGZ microglia via CX3CL1-
CX3CR1 signaling (Vukovic et al., 2012). Pathological events like status 
epilepticus can also induce hippocampal neurogenesis. Two days after a 
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pilocarpine-induced status epilepticus, an IGF-1 dependent increase of SGZ 
neuroblasts was observed. IGF-1 was mainly produced by microglia close to the 
SGZ (Choi et al., 2008). In a further study, adult rats underwent adrenalectomy 
and the subsequent deprivation of endogenous glucocorticoids resulted in NPC 
proliferation in the SGZ. Interestingly, this increase in neurogenesis correlated 
with augmented numbers of non-ramified SGZ microglia (Battista et al., 2006). 
 Furthermore, SGZ microglia were shown to regulate NPC numbers not 
only via secreted factors but also via phagocytic activity. Meticulous fate-
mapping studies demonstrated that the majority of newly born SGZ NPCs 
undergo apoptosis within the first 4 days after division and are rapidly 
phagocytosed by resident microglia (Sierra et al., 2010). It is hypothesized that 
microglia may phagocytose live cells and thereby actively regulate 
neurogenesis (Brown and Neher, 2014). 
 Thus, different models of induced SGZ neurogenesis demonstrate that 
microglial numbers are linked to postnatal SGZ neurogenesis, although the 
results are heterogeneous. Additionally, phagocytosis of newly born NPCs is a 
common feature of microglia in the healthy adult hippocampus. 
 
 As previously described, neurogenesis in the SVZ and SGZ are similar 
but not identical. Therefore, microglia may have different functions among these 
two stem cell niches. In a pivotal study, Cunningham and colleagues (2013) 
addressed extensively the role of microglia in the SVZ during late embryonic 
and early postnatal development across different species. Amoeboid-shaped 
microglia accumulated specifically in the developing SVZ in rat, macaque and 
human brains in utero and actively regulated the number of NPCs via 
phagocytosis. Reducing microglial activity by administration of doxycycline or 
depleting microglia by liposomal clodronate markedly increased the number of 
NPCs, while inversely, enhancing microglial activity by LPS injection decreased 
it. As described in the previous chapter, microglia display an embryonic 
phenotype until the end of the second postnatal week before adopting an adult 
state (Matcovitch-Natan et al., 2016). Shigemoto-Mogami and colleagues 
(2014) demonstrated in a combination of in vitro and in vivo approaches that 
during this critical time period, downregulation of microglial activity by 
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minocycline (which acts similarly to doxycycline) leads to a decrease in SVZ 
neurogenesis via reduction of microglial-derived IL-1β, IL-6, TNF-ɑ and IFN-γ. 
Interestingly, a mix of function-blocking antibodies against these 4 cytokines 
reproduces the effect of minocycline on neurogenesis in vitro, whereas inhibition 
of individual cytokines is insufficient. Vice-versa, addition of IL-1β and IFN-γ in 
low concentrations (1 ng / ml) promotes neurogenesis. Hence, the release of 
the right amount and combination of cytokines by microglia support early 
postnatal neurogenesis. In line with these results, low-dose administration of 
IFN-γ acts proneurogenic in the adult SVZ (Pereira et al., 2015) and 
pharmacological inhibition of IL-6 reduces the number of SVZ-derived 
neurospheres after HI (Covey et al., 2011). These findings suggest that 
mediators, including IL-1β, IL-6, TNF-ɑ or IFN-γ, which are on one hand 
detrimental for neurogenesis in the setting of excessive inflammation (Monje et 
al., 2003), are on the other hand beneficial or even essential for neurogenesis if 
appropriately secreted within the right microenvironment. 
 Furthermore, SVZ microglia may have inherent properties which 
distinguishes them from microglia of other brain regions. In the adult mouse, 
SVZ microglia are more proliferative than microglia in the striatum or corpus 
callosum (Goings et al., 2006) and culturing microglia from the SVZ yields in 20 
times more cells than culturing microglia from non-neurogenic brain regions 
(Marshall et al., 2008). However, when SVZ microglia are co-cultured with 
cortical tissue, their proliferative capacity is reduced, suggesting that microglia 
sense their environment and adapt to it (Marshall et al., 2014). Furthermore, 
SVZ-derived primary cell cultures, but not cerebellum-derived cultures, retain 
the ability for self-renewal for more than 300 passages. However, the SVZ cell 
cultures rapidly lose their capacity to differentiate into neuron-specific class III β 
-tubulin (TUJ1)+ NPCs after the tenth culture passage, which is concurrent to 
the depletion of primary microglial cells. On the other hand, the capacity to form 
neuroblasts is reconstituted in passage 300 SVZ cell cultures if they are 
supplemented with conditioned medium from passage 3 SVZ cultures in which 
microglia are still present in high numbers. Importantly, differentiating passage 3 
SVZ cell cultures have significantly reduced numbers of TuJ1+ NPCs if 
microglia are previously depleted (Walton et al., 2006). Vice-versa, 
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supplementation of SVZ microglia but not cortical microglia increase the 
numbers of TuJ1+ NPCs in murine SVZ cultures (Marshall et al., 2014). 
 
 Further in vitro data point out that the neurotrophic effect of microglia 
depends on the mode of activation. Microglia activated by IL-4 produce high 
levels of IGF-1, downregulate TNF-ɑ and promote adult NPC differentiation to 
oligodendrocytes, whereas low levels of IFN-γ stimulation favour neurogenesis. 
On the other hand, activation by LPS inhibits NPC differentiation (Butovsky et 
al., 2005; 2006). These findings exemplify that microglial activation is versatile 
and context-dependent. Though, generally accepted definitions of in vivo 
microglial activation states are still pending. 
 
 As previously mentioned, microglial phagocytosis is crucial for tissue 
homeostasis in the hippocampus (Sierra et al., 2010). "Eat-me" signals, such as 
phospholipid phosphatidylserine, are important for the identification and 
subsequent phagocytosis of apoptotic or potentially stressed but still live cells 
(Brown and Neher, 2014; Arandjelovic and Ravichandran, 2015). Phospholipid 
phosphatidylserine is a component of the plasma membrane that is normally 
located on the intracellular side of the cell membrane, but is externalized to the 
cell surface upon injury or stress. It is then recognized by the TAM receptors 
Mertk and Axl on microglia which induce phagocytosis. In adult wilde-type mice, 
the SVZ is void for the apoptotic marker cleaved-caspase-3 (CC3), underlining 
that microglial phagocytosis is highly efficient. However, in Axl−/− Mertk−/− mice, 
CC3+ cells accumulate in the SVZ and along the rostral migratory stream while 
bromodeoxyuridine (BrdU)+ cells in the olfactory bulb increase by 70 % 
(Fourgeaud et al., 2016). These findings suggest that TAM receptor-mediated 
microglial phagocytosis is crucial for tissue homeostasis in the SVZ and 
neuroblast survival along the rostral migratory stream. 
 
 Two additional aspects add even more complexity to the regulatory role 
of microglia on NPCs. First, neurotrophic support by microglia may not be 
limited to their close surrounding but may also affect remote regions. For 
instance, the survival of early postnatal cortical layer V neurons appears to be 
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directly dependent on the secretion of IGF-1 and CXCL3-CXCR3 signaling of 
supraventricular microglia (Ueno et al., 2013). Secondly, microglia-NPC 
interaction is not unilateral but reciprocal. NPCs regulate microglial proliferation, 
migration, and phagocytosis via the secretion of immunomodulatory proteins, 
including vascular endothelial growth factor (VEGF) (Mosher et al., 2012; Liu et 
al., 2013). 
 
 Brain ischemia temporarily induces neurogenesis by mechanisms which 
are still not completely understood (Zhang et al., 2008). The role of microglia in 
this ischemia-induced neurogenesis was so far only addressed by a few 
studies. Thored and colleagues (2009) showed that after a 2 h middle cerebral 
artery occlusion (MCAO) in the rat, SVZ microglia ipsilateral to the ischemic 
injury accumulate over 16 weeks with a peak at 6 weeks. These microglia 
express CD68, a lysosomal marker of microglial activation and neurotrophic 
IGF-1. The authors thus concluded that SVZ microglia support post-ischemic 
neurogenesis by adopting a proneurogenic phenotype. However, a similar study 
with only 30 min MCAO did not lead to SVZ microglial accumulation (Chapman 
et al., 2015), suggesting that the degree of injury is crucial for the SVZ microglial 
response. Interestingly, a partial depletion of SVZ microglia by intrathecal 
administration of anti-CD11b saporin-conjugated antibodies, followed by 2 h 
MCAO does neither affect the number of NPCs in the striatum nor alter their 
migratory distance from the SVZ (Heldmann et al., 2011). However, this 
depletion method does not achieve a complete eradication, because the 
CD11b+ microglia define only a subpopulation of all SVZ microglia. While the 
antibody treatment successfully reduces the number of CD11b+ microglia by 
73%, it reduces the number of all SVZ microglia by only 43%. Importantly, the 
number of CD68+ microglia is not affected by the antibody depletion treatment. 
 
 In conclusion, there is growing evidence that microglia in the neurogenic 
niches play a major role in NPC regulation through phagocytosis and secretion 
of factors which promote neurogenesis. The interaction between microglia and 
NPCs seems to be considerably dependent on the microenvironment. Limited 
data suggests that SVZ microglia support neurogenesis after ischemic stroke in 
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the adult rodent. Further studies implicate that in the early postnatal SVZ, 
endogenously activated microglia are per se neurotrophic. So far, the impact of 
HI on SVZ microglia during this time period has not been addressed. 
 
 
3.3.4. Microglia and neonatal HI 
 
 For decades, the microglial activation upon pathological stimuli was 
thought to reflect an uniform response with neurotoxic effects (Kettenmann et 
al., 2011). First evidence of such neurotoxic effects derived from in vitro 
experiments in the early 1990s, where microglia were stimulated by high 
concentrations of pro-inflammatory LPS, IFN-γ or TNF-α. Meanwhile, the 
limitations of such artificial in vitro experiments became evident (Hellwig et al., 
2013). 
 Further research indicated that the microglial responses upon 
pathological stimuli were more diverse than previously anticipated and involved 
not only pro-inflammatory but also neuroprotective mechanisms. Various 
attempts were made to categorize the different microglial reactions into either 
beneficial or detrimental for the CNS. The M1 / M2 polarization paradigm for 
microglial characterization emerged from in vitro observations in macrophages. 
Macrophages express different sets of markers upon stimulation by T-helper 
cell type TH1-derived IFN-γ or TH2-derived IL-4. In analogy to TH1 and TH2 cells, 
the corresponding macrophage cell types are called M1 and M2, respectively. 
The IFN-γ induced M1 phenotype is defined as the "classical" activation, which 
is characterized by expression of pro-inflammatory cytokines including TNF-α, 
IL-1β, and IL-6, as well as induction of reactive oxygen species-generating  
inducible nitric oxidase (iNOS) and nicotinamide adenine dinucleotide 
phosphate (NADPH) oxidase. In contrast, the IL-4 induced M2 phenotype is 
defined as the "alternative" activation, which is characterized by secretion of 
anti-inflammatory cytokines, such as IL-10 and transforming growth factor-β 
(TGF-β), neurotrophic factors (including IGF-1 and BDNF), and induction of 
arginase 1 (Arg1). Due to the close similarities of microglia and macrophages, 
the M1 / M2 polarization paradigm was subsequently applied to microglia with 
   3. Introduction 
24 
M1 activation characterized as pro-inflammatory and neurotoxic, and M2 
activation as anti-inflammatory, neurogenic and regenerative (Hu et al., 2015). 
Consequently, this polarization paradigm is used in numerous studies on 
microglial characterization in the context of acute ischemia and neonatal HI (e.g. 
Hellström-Erkenstam et al., 2016). 
 However, the M1 / M2 polarization paradigm was shown to have major 
limitations and increasing evidence even suggests that it is inadequate to 
describe microglial activation in vivo (Ransohoff, 2016). Indeed, characteristic 
markers for M1 or M2 polarization derive from in vitro experiments and cannot 
be reproduced in vivo. In opposite, transcriptome studies of isolated microglia 
from various animal models of neurodegenerative diseases including 
Alzheimer's disease (AD) and amyotrophic lateral sclerosis (ALS) do not display 
a relevant tendency of microglia toward the M1 or M2 phenotype (Holtman et 
al., 2015). Furthermore, accumulating evidence demonstrate that microglia and 
macrophages co-express distinct M1 and M2 markers concurrently even at a 
single-cell level and that the expression pattern of M1 / M2 markers is merely 
random (Chiu et al., 2013; Holtman et al., 2015; Szulzewsky et al., 2015; 
Morganti et al., 2016; Kim et al., 2016), leading the M1 / M2 paradigm ad 
absurdum. In consequence, key opinion leaders on microglial research suggest 
to no longer rely on the M1 / M2 polarization paradigm when describing 
microglial phenotypes in vivo (Ransohoff, 2016; Colonna and Butovsky, 2017). 
Undeniably, more in vivo studies are needed to establish a better approach on 
microglial characterization. 
 
 Studies on microglia in the context of ischemia are further complicated by 
the fact that microglia are immunohistochemically not distinguishable from 
invading macrophages (Hellwig et al., 2013). Invading macrophages are thought 
to play a different role than microglia after ischemic injury (Ritzel et al., 2015; 
Kim and Cho, 2016), but little is yet known about their long-term fate in the CNS 
after the injury (Garcia-Bonilla et al., 2016). Importantly, conditional depletion of 
microglia after brain ischemia in the adult rodent leads to increased stroke size 
and dysregulation of neuronal network activity (Lalancette-Hebert et al., 2007; 
Szalay et al., 2016), suggesting that overall, microglia are rather protective than 
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neurotoxic after ischemia. Nonetheless, our understanding of the microglial role 
in ischemic stroke is still incomplete and demands further investigations. 
 
 The pathogenesis of ischemic brain injury in the early postnatal brain 
shares many features of that in the adult brain, but there are also significant 
differences due to immaturity of both the CNS and the immune system. Most 
noteworthy among those differences is a more rapid proliferation and 
accumulation of microglia / macrophages after neonatal brain injury, which is 
likely due to their different developmental stage (Vexler and Yenari, 2009). 
Thus, the microglial reaction to brain injury is greatly affected by age which 
needs to be considered when comparing findings among different studies. 
 The temporal characterization of inflammation after neonatal HI indicates 
a rapid inflammatory response in the CNS within the first 3 hours which lasts up 
to 7 months (Bonestroo et al., 2013). During this time period, microglia / 
macrophages are most prominent during the first two weeks after the injury 
(Winerdal et al., 2012). Flow cytometry analysis from a neonatal MCAO model 
indicate that the majority of CD11b+ CD45+ cells in the perilesional tissue are 
CD45+low microglia rather than CD45+high macrophages (Denker et al., 2007). 
By using the double transgenic mouse line CX3CR1GFP/+CCR2RFP/+, where 
green-fluorescent CX3CR1+ microglia can be distinguished from red-fluorescent 
CCR2+ macrophages, it is shown that resident microglia outnumber infiltrating 
macrophages in the injured hippocampus for up to 28 days after neonatal HI 
(Umekawa et al., 2015). 
 Endogenously activated microglia accumulate specifically in the 
periventricular white matter during mid to late gestation in humans (Billiards et 
al., 2006) and until the second postnatal week in rodents (Hristova et al., 2010; 
Shigemoto-Mogami et al., 2014). Periventricular white matter damage is a 
hallmark of HIE in preterm infants. Thus, the spatio-temporal accumulation of 
activated microglia is thought to be mainly responsible for the periventricular 
white matter vulnerability to hypoxia through an excessive microglia-mediated 
inflammatory response (Khwaja and Volpe, 2008; Kaur et al. 2013). 
 On the other hand, microglia promote repair and regeneration in the 
subacute phase after injury through phagocytosis of debris and release of 
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neurotrophic mediators (Alvarez-Díaz et al., 2007; Neumann et al., 2009). 
Importantly, depletion of microglia in a neonatal MCAO model actually increases 
brain injury size and the risk of post-ischemic hemorrhagic transformation, 
hence suggesting that the presence of microglia is rather beneficial than 
detrimental for the injured brain (Faustino et al., 2011; Fernandez-Lopez et al., 
2016). 
 
 To conclude, until recently, the microglial role after neonatal HI was 
heavily influenced by the M1 / M2 polarization paradigm on microglia to adopt 
either an aggravating (M1) or a supportive (M2) phenotype. However, 
accumulating evidence strongly suggests that this categorization is rather 
artificial and insufficient to characterize microglial function in vivo. The current 
findings on microglia in neonatal HI remain controversial with microglia 
promoting damage in the acute phase and repair in the post-acute phase. More 
studies are needed to disassemble the numerous microglial effects in neonatal 
HI. 
 
 
3.4. The aim of this study 
 
 Recent findings indicate that microglia in the neurogenic niches are a key 
modulator of neurogenesis (Sato, 2015) and are therefore a potential 
therapeutic target to enhance regeneration after neonatal HI. Recently, 
microglia were reported to adopt a supportive phenotype in the adult SVZ after 
ischemic stroke (Thored et al., 2009). There are however important differences 
between the adult and maturing brain with regard to microglial characteristics. 
Early postnatal microglia do not yet express an adult phenotype (Matcovitch-
Natan et al., 2016; Bennett et al., 2016) and are endogenously activated in the 
SVZ (Shigemoto-Mogami et al., 2014). In consequence, they may respond 
differently than adult microglia to brain injury. So far, microglia in non-injured 
brain regions, including the SVZ, have not been extensively characterized after 
HI. Therefore, we thought to investigate the impact of HI on the microglial 
phenotype in the early postnatal SVZ.  
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4. Methods 
 
 
4.1. Animals 
 
 All animal experiments were approved by the local veterinarian 
authorities and complied with the Swiss animal welfare guidelines. Sprague-
Dawley rats were bred in-house and the day of birth was considered as P0. 
 
 
4.2. HI surgery 
 
 P7 rat neonates were randomly assigned to sham or HI surgery, with a 
balanced representation of both sexes among the two surgery groups. One hour 
prior to surgery, animals were injected intraperitoneally with buprenorphine 
(0.03 mg / kg body weight). Anesthesia was induced with 5 % isoflurane and 
maintained with 3 % isoflurane during the surgery. The HI surgery consisted of 
a modification of the Rice-Vannucci model (Rice et al., 1981): the right CCA was 
exposed and temporarily clipped with a Sugita 4mm aneurysm mini clip 
(Mizuho) and the skin incision temporarily sutured. Animals recovered for 10 
min on a heating pad and were then placed for 40 min into a hypoxic chamber 
constantly flushed with a 8 % oxygen / 92 % nitrogen gas mixture (2 L / min), 
that was immersed in a temperature-controlled water bath to maintain an air-
temperature of 37.5 °C. Animals then recovered for 10 min on a heating pad 
and were briefly anesthetized with isoflurane for clip removal and permanent 
skin suture. This procedure resulted in a cortico-striatal HI injury in the 
hemisphere ipsilateral to the side of CAA surgery. The sham surgery consisted 
of CCA exposure without temporary occlusion and without hypoxia exposure. 
 
4.3. BrdU administration and brain collection for stainings 
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 A first group of 30 animals was used for IHC purposes (n=5 animals for 
sham and HI per time point, respectively). Animals received daily single 
intraperitoneal BrdU injections (100 mg / kg body weight, Sigma) for 3 
consecutive days before sacrifice (Fig. 2A). 
 Animals were then sacrificed at P10, P20 or P40 to reflect acute, 
subacute and chronic stages after HI, under deep anesthesia by transcardiac 
perfusion with normal saline, followed by 4 % paraformaldehyde (PFA) in 0.1 M 
phosphate buffer pH 7.4 (PB). Brains were post-fixed in 4 % PFA in PB for 48 h 
at 4° C, cryoprotected in consecutive 15 % and 30 % sucrose solutions, 
embedded in OCT (Leica Biosystems) and cryosectioned. Coronal free-floating 
sections (30 µm) were stored at -20° C in a cryoprotectant solution (30 % 
ethylene glycol, 30 % sucrose in PB) until staining. 
 
 
4.4. Cresyl violet staining and selection of animals with ipsilateral brain 
injury 
 
 Coronal brain sections (interval 180 µm) were mounted on superfrost 
plus slides (Menzel), stained with 0.1 % cresyl violet acetate (Sigma) and 
scanned (Nikon Eclipse TI-E microscope). Brain sections including the anterior 
SVZ between 0.40 rostral to -0.20 caudal to bregma (in P10 rats and 
corresponding coordinates for the P20 and P40 rats, respectively) (Khazipov et 
al., 2015) were investigated in this study. Two investigators (UF, CB) 
independently assessed HI injury using ImageJ software (Version 
2.00rc.43/1.50e) and the results were averaged. The size of HI injury was 
calculated by subtracting the intact area in the ipsilateral hemisphere from the 
total area of the contralateral hemisphere (Tuor et al., 1993) in 3 serial cresyl 
violet sections. Only HI animals without histological signs of HI injury in the 
anterior SVZ were included in this study. 
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4.5. Immunohistochemistry 
 
 Brain sections were washed in Tris-buffered saline (TBS), incubated in 
blocking buffer (TBS with 2% fish gelatine, 0.3 % triton X-100, Sigma) for one 
hour at room temperature (RT), then incubated with primary antibodies (Table 
1) overnight at 4° C in blocking buffer, washed repetitively with TBS, and 
incubated with the corresponding species-specific Alexa-Fluor (488, 546, 555, 
647)-conjugated Donkey or Goat (H+L) secondary antibodies (ThermoFisher) in 
blocking buffer (1:2000) for one hour at RT. Sections were counterstained with 
0.5 µg / mL DAPI (Sigma) before mounting on superfrost slides with ProLong 
Gold (ThermoFisher). For BrdU labelling, sections were pretreated with 2 N HCl 
for 30 min at RT before the blocking step. For proliferating cell nuclear antigen 
(PCNA) labelling, antigen-retrieval was performed for 5 min at 80° C in Target 
retrieval solution (Dako) before the blocking step. 
 
Host / primary antibody Producer Concentration for histology Concentration for cytology 
Mouse / anti-BrdU BD Bioscience 1:200  
Rabbit /anti-CC3 Cell Signaling 1:200  
Mouse / anti-CD68 R&D Systems 1:2000  
Guinea pig / anti-DCX Merck Millipore 1:2500 1:2000 
Rabbit / anti-Iba1 Wako 1:2000 1:1000 
Goat / anti-Iba1 Abcam 1:1000  
Rabbit / anti-Ki67 Abcam 1:1000  
Mouse / anti-Nestin Millipore  1:500 
Rabbit / anti-PAX6 Biolegend 1:1000  
Mouse / anti-PCNA DAKO 1:700  
Mouse / anti-PSA-NCAM Abcam 1:400  
Rabbit / anti-SOX2 Abcam 1:500  
Table 1: Primary antibodies used for IHC tissue and cell culture stainings. 
 
 
4.6. Brain section image acquisition and analysis 
 
 20x wide-field immunofluorescence images from brain sections were 
acquired on a Eclipse TI-E microscope (Nikon), and 40x confocal 
immunofluorescence image stacks (330 x 330 µm, 11 µm depths, step size 0.5 
µm) on a CSU-W1 microscope (Visitron Systems). Representative 40x images 
for depicting microglial activation were acquired on a LSM 710 confocal 
microscope (Zeiss). All quantitative analyses were conducted in 3 brain sections 
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(interval 180 µm) and mean values calculated per animal. Image acquisition 
settings were identical for all stainings. 
 
 
4.6.1. SVZ area and microglial quantification 
 
 Quantification of SVZ area and microglial morphology, density and 
activation was performed manually with ImageJ from wide-field IHC images. 
The SVZ area was defined by its DAPI+ cellular density. The microglial 
morphology was classified into 3 categories: i) amoeboid with roundish cellular 
shape without cellular processes, ii) intermediate with irregular cellular shape 
and short processes and iii) ramified with cellular extensions which extended at 
least two-fold the diameter of the microglial cell body (Fig. 6A). The microglial 
density was calculated as the number of Iba1+ cells per area in 3 brain regions: 
i) in the SVZ, ii) in a 1600 x 200 µm rectangle including layers I-VI of the M2 
supplementary motor cortex (CX), and in three 150 µm squares which were 
symmetrically distributed in the supraventricular median corpus callosum (CC) 
(Fig. 4A). The expression of CD68 is a marker for microglial activation 
(Shigemoto-Mogami et al., 2014). Microglial activation was calculated as the 
number of CD68+ Iba1+ cells per total number of Iba1+ cells in each region. 
 
 
4.6.2. Quantification of cell proliferation and microglial ball-and-chain 
phagocytosis 
 
 PCNA+ and paired box 6 protein (PAX6)+ cells in the most medial part of 
the dorsolateral SVZ were manually counted in a 50 µm x 50 µm square with 10 
µm depth with ImageJ from confocal stack images. Only PCNA+ and PAX6+ 
cells being fully included within the square were counted. Microglial proliferation 
(number of BrdU+ Iba1+ cells per total number of Iba1+ cells) and ball-and-
chain phagocytosis (number of ball-and-chain shaped phagocytic pouches per 
total number of Iba1+ cells) in the dorsolateral SVZ or CX were manually 
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quantified in 3D-reconstructed confocal stack images with Imaris software 
(Vers. 7.6.5, Bitplane). In Imaris, the "mask channel" function was applied to 
highlight BrdU+ Iba1+ cells.  
 
 
4.7. SVZ microglia isolation and RNA purification  
 
 A second group of 24 animals underwent sham or HI surgery at P7 for 
ipsilateral SVZ microglial isolation at P10 or P20 and subsequent gene 
expression analysis (n=6 for sham and HI per time point, respectively). At P10 
or P20, animals were deeply anesthetized and perfused with ice-cold normal 
saline. Brains were extracted and kept in ice-cold Hank's balanced salt solution 
(HBSS) (Sigma). The region of the anterior SVZ was coronally cut with sterile 
razor blades in 2 mm thick sections and the ipsi-dorsolateral SVZ from two 
sections microdissected under a dissection microscope (Leica). Dorsolateral 
SVZ tissue was only collected if the HI injury did not affect the ipsilateral SVZ or 
the adjacent median striatum / corpus callosum (microscopic assessment 
during preparation). SVZ tissue from individual animals was separately collected 
and processed at 4°C. The SVZ tissue was washed (centrifugation at 300 g for 
5 min, followed by aspiration of the supernatant), dissociated with the papain 
neural dissociation kit (Miltenyi), filtered through a 40um strainer, washed again 
and magnetically labeled with mouse anti-rat CD11b microbeads (1:200) 
(Miltenyi) for 20 min. CD11b+ cells were ferromagnetically isolated using MS 
columns (Miltenyi) following the manufacturer’s instructions. The purity of 
CD11b+ sorted cells was confirmed by flow cytometry (see chapter "4.13. Flow 
cytometry"). Due to the very low cell yield, simultaneous flow cytometry analysis 
and RNA collection was not possible. Therefore, purity of isolated CD11b+ cells 
was confirmed from contralateral CX tissue undergoing the same isolation 
procedure as the SVZ tissue. Isolated CD11b+ cells were immediately 
processed with the Arcturus PicoPure RNA isolation kit (ThermoFisher 
Scientific) including DNase treatment and temporary storage at -80° C after 
extraction buffer treatment. RNA isolation was then completed batch-wise. RNA 
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integrity of all samples was measured with the RNA 6000 Pico Kit (Agilent) on 
the 2100 Bioanalyzer (Agilent). 
 
 
4.8. Microglial transcriptome analysis 
 
 Sample preparation for microarray processing was performed externally 
at Life&Brain GmbH, Bonn, Germany. In brief, 500 pg total RNA per sample 
were reverse transcribed into cDNA using the GeneChip WT Pico Assay Kit 
(Affymetrix) in a two-step process according to the manufacturer’s instructions. 
The cDNA was subsequently fragmented, labeled and hybridized to the 
GeneChip Rat Transcriptome Array 1.0 (Affymetrix). After staining, scanning 
was performed on a GeneChip Scanner 3000 (Affymetrix). 
 The raw microarray data was normalized using the R/Bioconductor 
package oligo (version 1.38.0). In brief, CEL files were read-in and 
subsequently normalized using the function rma. Probe sets were annotated 
with the affycoretools package (version 1.46.4). Entrez IDs with multiple probe 
sets were filtered for the probe set with the highest variance. One sample (P20 
sham SVZ) was identified as an outlier and removed from further analysis. The 
limma package (version 3.30.7) was used for differential gene expression 
analysis. One set of contrast was defined to evaluate the treatment differences 
at both time points. P-values were adjusted for multiple testing using the 
Benjamini and Hochberg false discovery rate (FDR) and genes with a FDR < 
0.05 were considered as significant. To compare the present data set with M1 
or M2 polarization markers, we used published microarray data sets from 
microglia stimulated with either LPS or IL-4 (Freilich et al., 2013). The 15 most 
differentially expressed genes (FDR < 0.05) of microglia(LPS) and microglia(IL-
4) were used to define gene sets for M1 or M2, respectively. Gene sets defined 
in the Kyoto Encyclopedia of Genes and Genomes (KEGG) (version dowloaded 
on 9. February 2017) were tested for differential enrichment using the limma 
function kegga. Principal component analysis and pathway-enrichment graphs 
were generated using R base graphics while heat maps for specified gene sets 
are based on the ComplexHeatmap package (version 1.12.0).  
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4.9. Quantitative real-time PCR validation 
 
 The microarray results were validated by quantitative real-time 
polymerase chain reaction (qRT-PCR) from additional SVZ samples that were 
not used for the microarray (n=2 for sham or HI per time point, respectively). 
RNA from the two samples of the same condition were pooled (500 pg per 
sample). Due to the low RNA amount (1 ng) per pooled sample group, we 
decided to validate the expression levels of microglial Igf-1. Pooled RNA was 
reverse-transcribed with the QuantiTect Reverse Transcription Kit (Qiagen) and 
qRT-PCR was performed in triplicates using Fast SYBR Green MasterMix 
(Roche) on a LightCycler 480 (Roche). Primers for Igf-1 and β-actin were 
commercially acquired (QuantiTect, Qiagen). Runs were normalized to the 
housekeeping gene β-actin by measuring ΔCT. The 2-ΔΔCT method was used for 
the calculation of the Igf-1 fold change (FC) of HI vs. sham groups per time 
point. 
 
 
4.10. Primary neurosphere generation from SVZ tissue and microglial 
depletion 
 
 A third group of 18 animals was used for primary cell culture 
experiments. Animals underwent sham or HI surgery at P7 (n=3 sham, n=6 HI 
per experiment, n=3 independent experiments) and were deeply anesthetized 
and decapitated at P10. Rat heads were immersed in 70 % ethanol for 30 sec 
and kept in ice-cold HBSS until the sterile dissection. Coronal sections of 6 mm 
thickness of the anterior SVZ were prepared as described above. Rectangular 
tissue blocks including the whole ipsi- or contralateral SVZ and the adjacent 
medial striatum were isolated. In sham animals, all SVZ tissue blocks were 
pooled per experiment, whereas in HI animals, ipsi- and contralateral tissue 
blocks were pooled separately, resulting in 3 tissue groups: ipsilateral HI (HI 
ipsi), contralateral HI (HI contra), and bilateral sham tissue blocks (sham) (Fig. 
16A). The pooled tissue samples were washed, dissociated with the papain 
neuronal dissociation kit (Miltenyi) and filtered through a 70 µm strainer. The cell 
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suspension was again washed and counted with trypan blue on a TC20 
automated cell counter (Bio-Rad). Dissociated cells were seeded at a density of 
0.3 Mio in uncoated 24-well cell culture wells (Corning). Cells were incubated in 
500 µl neuronal expansion medium (DMEM/F12 1:1, Gibco; with N2 
supplements [human apo-Transferrin, 100 mg / L; insulin, 25 mg / L; putrescine, 
100 µM; sodium selenite, 30 nM; Sigma]; penicillin/streptomycin, 100 µg / ml, 
Gibco; glutaMAX, 2 mM, Gibco). The cell culture plates were incubated at 37° C 
in 5 % CO2. The medium was completely replaced after 2 h, followed by 
microglial depletion according to 3 conditions (at least 3 wells per condition per 
tissue group):  addition of i) microglia-targeting mouse anti-CD11b saporin-
conjugated antibodies (anti-CD11b SAP, 0.35 µg / ml) (Advanced Targeting 
Systems), ii) unspecific mouse IgG saporin-conjugated antibodies (IgG SAP, 
0.35 µg / ml) (Advanced Targeting Systems) or iii) no antibodies (control) (Fig. 
16A). Cell cultures were supplemented daily with recombinant human fibroblast 
growth factor (FGF) (20 ng / ml, R&D Systems) and recombinant human 
epidermal growth factor (EGF) (20 ng / ml, Peprotech). Half of the neuronal 
expansion medium was replaced at 3 days in culture (DIC). Neurosphere size 
and area were assessed after 6 DIC. 
 
 
4.11. Immunocytochemistry 
 
 After 6 DIC, wells were fixed for 15 min in 4 % PFA at RT. The 
immunofluorescence staining (Table 1) was identical to the one described in 
chapter "4.5. Immunohistochemistry". 
 
 
4.12. Cell culture image acquisition and analysis  
 
 Two 2.5x wide-field images per well were acquired on a Axiovert 200 
microscope (Zeiss), representing 25 % of the total well surface. Number and 
area of neurospheres equivalent to a diameter of > 45 µm were automatically 
counted in ImageJ. For each experimental condition, the data from 3 wells were 
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averaged and extrapolated to calculate neurosphere numbers per well. For the 
comparison of neurosphere area distribution, the full data set was used. 
Qualitative 40x fluorescence images from immunohistochemically stained wells 
were acquired on a LSM 710 confocal microscope (Zeiss). 
 
 
4.13. Flow cytometry 
 
 Dissociated samples were washed and stained with mouse anti-CD11b-
FITC (1:200) (Bio-Rad) and mouse anti-CD45-PE (1:200) (Bio-Rad) in buffer 
solution (phosphate-buffered saline pH 7.4 [PBS], 0.5% bovine serum albumin, 
2 mM Ethylene-diaminetetraacetic acid [EDTA]) at 4° C for 20 min. Samples 
were then washed again in buffer solution before measuring the fraction of 
CD11b+ CD45+ cells on an Accuri flow cytometer (BD Bioscience). All data 
were analyzed with FlowJo software (version 10.2). 
 
 
4.14. Statistical analysis 
 
 All data sets with the exception of the microarray data (see above) were 
analyzed in Prism software (GraphPad, Version 6). All data are presented as 
mean ± standard deviation (SD) if not stated otherwise. Statistical analysis was 
performed with Two-way ANOVA with Tukey post-hoc test or One-way ANOVA 
with Holm-Sidak post-hoc test. P-values < 0.05 were considered as significant. 
Correlations were computed with two-tailed Pearson correlation coefficients or 
nonparametric Spearman correlation. Countings from ipsi- and contralateral 
sham hemispheres did not show significant differences, thus only ipsilateral 
sham data (sham) were used for statistical comparison. 
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5. Results 
 
 
5.1. SVZ transiently enlarges while NPC density remains unaltered after HI 
 
 The Rice-Vannucci model of neonatal HI is known to result in a high 
variability of HI injury size (Fig. 1). Two investigators independently assessed 
the size of HI injury (Pearson coefficient r=0.96, 95% confidence interval [CI] 
0.91-0.98, p < 0.0001, n=34). Based on predefined criteria, a total of 15 HI 
animals without histological signs of HI injury in the anterior SVZ were selected 
for further histological studies with a median 49 % hemispherical HI injury size 
(interquartile range 35 - 60%). 
 As previously reported (Plane et al., 2004; Ong et al., 2005; Yang and 
Levison 2006), HI injury induces a temporary enlargement of the SVZ and an 
increase in NSC / NPC proliferation (Buono et al., 2015). We measured the area 
of the total SVZ in sham and HI animals at 3 time points after surgery, reflecting 
acute, subacute and chronic stages of HI injury (Fig. 2). HI induced an early 
increase at P10 in SVZ size that was most prominent in the ipsilateral SVZ (0.35 
[mean] ± 0.05 [SD] mm2) as compared to the sham SVZ (0.26 ± 0.03 mm2, p < 
0.004). This early enlargement was transient and at P40, ipsilateral HI SVZ 
(0.23 ± 0.06 mm2) adjusted to sham SVZ size (0.20 ± 0.02 mm2). Overall, the 
SVZ size in both HI and sham animals markedly decreased with age. 
 Next, we quantified the density of proliferating PCNA+ and PAX6+ cells 
in the dorsolateral SVZ. Due to the vast cellular density and extensive 
neurogenesis in the early postnatal SVZ, we used the nuclear marker PAX6 for 
a most accurate cell counting. PAX6 is a transcriptional factor that is sufficient to 
induce a neurogenic fate in NPCs in the early postnatal SVZ (Jang and 
Goldman, 2011). Our results showed that the densities of PCNA+, PAX6+ or 
PCNA+ PAX6+ cells were not markedly different between HI and sham SVZ at 
any time point (Fig. 3). These results are in line with previous findings of 
unaltered densities of proliferating cells after ischemic stroke (Chapman et al., 
2015). 
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Figure 2: The SVZ temporarily expanded in size after neonatal HI. (A) Experimental timeline for 
the in vivo studies. Animals were subjected to sham or HI surgery at P7 and sacrificed at P10, 
P20 or P40. BrdU was injected for 3 consecutive days before sacrifice (asterisk). (B) 
Representative images of the ipsilateral SVZ after sham and HI surgery at P10 and P40, 
respectively. (C) Quantification of the SVZ size after sham and HI surgery. Mean with SD (error 
bars), n=5 animals, Two-way ANOVA with Tukey post-hoc test, ** p < 0.01, *** p < 0.001, **** p 
< 0.0001. Scale bar for (B): 500 µm. 
 
 
 
Figure 3: HI did not affect the density of cells with neurogenic fate (PAX6) and proliferating cells 
(PCNA) in the SVZ. PAX6+ and PCNA+ cells were counted in a 50 µm square with 10 µm depth 
in the median dorsolateral SVZ. Mean with SD (error bars), n=3 animals. 
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5.2. SVZ microglia specifically accumulate and remain activated after HI 
 
 After ischemic stroke in the adult rat, ipsilateral SVZ microglia become 
activated and accumulate over weeks (Thored et al., 2009). Early postnatal 
microglia are yet not fully maturated (Matcovitch-Natan et al., 2016; Bennett et 
al., 2016) and are endogenously activated in the SVZ (Shigemoto-Mogami et 
al., 2014), which may affect their reaction to HI injury. We therefore analyzed 
the impact of HI injury on SVZ microglia by quantifying microglial density (Iba1+ 
cells per SVZ area) and the proportion of microglial activation (number of 
CD68+ Iba1+ cells per total number of Iba1+ cells) (Fig. 4). 
 In the ipsilateral HI SVZ, the microglial density significantly increased at 
P10 after HI as compared to the sham SVZ (ipsilateral HI SVZ, 911 ± 57 vs. 
sham SVZ, 519 ± 67 Iba1+ / mm2, p < 0.0001).  This accumulation was 
maintained until P40 (1041 ± 200 vs. 590 ± 66 p < 0.0001) (Fig. 4C). Likewise, 
HI strikingly increased the proportion of activated microglia at P10 in the 
ipsilateral HI SVZ when compared to the sham SVZ (0.53 ± 0.13 vs. 0.25 ± 0.07 
CD68+ Iba1+ / Iba1+, p <0.0001). This increase in activation was significantly 
different until P20 (0.26 ± 0.06 vs. 0.06 ± 0.03, p<0.006). With aging, the 
activation tremendously decreased in both ipsilateral HI SVZ (P10 0.53 ± 0.13 
vs. P40 0.08 ± 0.03, p < 0.0001) and sham SVZ (0.25 ± 0.07 vs. 0.02 ± 0.02, p 
≤ 0.001) (Fig. 4D). Thus, the ipsilateral SVZ microglia responded to HI injury 
with early accumulation and prolonged activation. Interestingly, the contralateral 
SVZ responded similarly, although to a lesser extent. 
 
 Next, we investigated if these findings were specific to the SVZ or also 
occured in other brain regions (Fig. 4A). We therefore performed equivalent 
measurements in the adjacent CX and CC. In the CX, the microglial density 
remained unchanged between HI and sham animals from P10 (ipsilateral HI 
CX, 299 ± 47 vs. sham CX, 310 ± 49 Iba1+ / mm2) until P40 (297 ± 28 vs. 266 ± 
6) (Fig. 4C). In the CC, the microglial density significantly increased in the HI as 
compared to the sham group at P10 (HI CC, 989 ± 238 vs. sham CC, 490 ± 49, 
p<0.0001) whereas they reduced to equal densities in the HI versus sham group 
until P40 (367 ± 31 vs. 328 ± 32) (Fig. 4C). 
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 HI increased the proportion of activated microglia in the CX (ipsilateral HI 
CX, 0.1 ± 0.12 vs. sham CX, 0.003 ± 0.004 CD68+ Iba1+ / Iba1+, p<0.003) and 
the CC (HI CC, 0.75 ± 0.13 vs. sham CC, 0.5 ± 0.17, p<0.01) at P10 before it 
drastically reduced in both HI and sham animals (Fig. 4D). Altogether, microglia 
in brain regions close to the SVZ were shortly activated after HI, but more 
importantly, did not demonstrate microglial accumulation and prolonged 
activation, as observed in the SVZ. 
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Figure 4: Microglia specifically accumulated in the SVZ and displayed prolonged activation after 
HI. (A) Diagram of the analyzed regions in the HI-affected (pale red) forebrain, including the 
SVZ (blue), the M2 supplementary motor CX (green) and the median CC (red). (B) 
Representative images of activated (CD68+) microglia (Iba1+) in the dorsolateral SVZ. (C) 
Quantification of the microglial density in different brain regions. (D). Quantification of the 
proportion of activated microglia in different brain regions. Mean with SD (error bars), n=5 
animals, Two-way ANOVA with Tukey post-hoc test, ns = non-significant, * p < 0.05, ** p < 0.01, 
*** p < 0.001, **** p < 0.0001. Scale bar for (B): 20 µm.  
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.5.3. SVZ microglia proliferate early after HI 
 
 Based on the above findings of microglial accumulation in the SVZ early 
after HI, we next investigated if this accumulation was due to early microglial 
proliferation. We administered BrdU for 3 consecutive days before sacrifice to 
identify the percentage of proliferating SVZ microglia (number of BrdU+ Iba1+ 
cells per total number of Iba1+) in the dorsolateral SVZ (Fig. 5). We found a 
constitutionally elevated microglial proliferation in sham animals at P10 as 
compared to P20 and P40. HI led to a significantly induced microglial 
proliferation in the ipsilateral SVZ as compared to sham SVZ at P10 (ipsilateral 
HI SVZ, 0.16 ± 0.04 vs. sham SVZ, 0.11 ± 0.01 BrdU+ Iba1+ / Iba1+, p < 
0.014). A concurrent analysis of Ki67+ Iba1+ proliferating microglia also 
depicted similar results overall, but with non-significant differences between HI 
and sham SVZs at P10 (data not shown), suggesting that the HI-induced 
proliferation mainly occurred before P10. 
 In comparison to the SVZ, the proportion of BrdU+ Iba1+ cells in the CX 
was already noticeably lower at P10 and insignificant between ipsilateral HI CX 
and sham CX (0.06 ± 0.03 vs. 0.05 ± 0.01) (Fig. 5). BrdU+ Iba1+ cells were 
practically inexistent in the CX at later time points (data not shown). Hence, 
microglia proliferated in the early postnatal brain and especially in the SVZ. HI 
further increased this proliferation within the first 3 days after HI. 
 
Figure 5: HI induced early proliferation of SVZ microglia. The relative proportions of proliferating 
(BrdU+) microglia (Iba1+) among total number of microglia were assessed in the dorsolateral 
SVZ and CX. Individual data shown as dots, bars as mean with SD (error bar), n=3 animals, 
Two-way ANOVA with Tukey post-hoc test, * p < 0.05, ** p < 0.01. 
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5.4. HI temporarily increases the proportion of amoeboid SVZ microglia 
 
 Next, we classified Iba1+ microglia in the dorsolateral SVZ upon their 
morphology into amoeboid, intermediate and ramified phenotypes (Fig. 6). 
Postnatal SVZ microglia are initially amoeboid-shaped before gradually 
adopting a ramified-"surveilling" morphology (Nimmerjahn et al., 2005; 
Shigemoto-Mogami et al., 2014). An amoeboid morphology is associated with 
increased activation, proliferation and phagocytosis (Kettenmann et al., 2011). 
To our knowledge, the morphology of early postnatal SVZ microglia has not 
been quantified before. 
  In both sham and HI, the proportion of amoeboid microglia decreased 
over time. Importantly, at P10, the percentage of amoeboid microglia in both 
ipsilateral (68.9 ± 25.2%) and contralateral HI SVZ (49.2 ± 27.6%) were 
strikingly increased as compared to amoeboid microglia in sham SVZ (6.8 ± 
7.4%, p ≤ 0.001). However, at P40, the percentage of amoeboid SVZ microglia 
became similar between HI and sham animals (ipsilateral HI, 0.9 ± 0.3 % vs. 
contralateral HI 1.4 ± 1.6 % vs. sham, 2.6 ± 1.1 %). In comparison, microglia in 
the CX remained ramified from P10 until 40 (data not shown). Thus, microglia in 
both ipsi- and contralateral SVZ reacted to HI with a temporary increase in 
amoeboid microglia. 
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Figure 6: HI transiently increased the proportion of amoeboid SVZ microglia. (A) Microglia were 
classified upon their morphology into (A1) amoeboid, (A2) intermediate or (A3) ramified 
subtypes. (B) Proportions of Iba1+ cells in the dorsolateral SVZ according to their morphology. 
Mean with standard error of the mean (error bar), n=3 animals, Two-way ANOVA with Tukey 
post-hoc test, ** p < 0.01, **** p < 0.001. Scale bar for (A): 10 µm. 
 
 
5.5. Increased number of ball-and-chain phagocytic SVZ microglia after HI 
 
 Phagocytosis is a key feature of microglia by which they regulate NPC 
numbers in the developing brain (Cunningham et al., 2013) and maintain tissue 
homeostasis in the adult neurogenic niches (Sierra et al., 2010; Fourgeaud et 
al., 2016). We next assessed microglial ball-and-chain type phagocytosis (Fig. 
7A) (Sierra et al., 2010) in the dorsolateral SVZ (number of Iba1+ ball-and-chain 
phagocytic buds per total number of Iba1+ cells) (Fig. 7).  
 In sham SVZ, ball-and-chain phagocytic buds among Iba1+ cells were 
most prominent at P10 and continuously decreased afterwards (P10, 0.52 ± 0.1 
vs. P40, 0.01 ± 0.1, p ≤ 0.0002) (Fig 7B). In contrast, the relative number of ball-
and-chain phagocytic buds increased in HI animals from P10 to P40 (ipsilateral 
HI SVZ, 0.06 ± 0.06 vs. 0.38 ± 0.15, p < 0.003), thus there was a significant 
difference at P40 between HI and sham ball-and-chain phagocytosis (p < 
0.009). Importantly, ball-and-chain phagocytosis is best recognized in ramified 
microglia, which are considerably low in the HI SVZ at P10, though non-ramified 
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microglia are highly phagocytic (Kettenmann et al., 2011). Therefore, ball-and-
chain defined phagocytosis likely underestimated the actual phagocytic activity 
of HI microglia at P10. Nevertheless, at P40, where the majority of Iba1+ cells in 
both HI and sham SVZ were ramified, ball-and-chain phagocytosis occurred 
more often in the HI SVZ as compared to the sham SVZ. 
 In contrast to the SVZ, microglial phagocytic activity in the CX was scarce 
at P10 (Fig. 7B) and undetectable afterwards (data not shown). 
 
 
Figure 7: SVZ microglia remained phagocytic after HI at P40. (A) A representative image of a 
microglia engulfing a pyknotic BrdU+ cell via ball-and-chain phagocytosis. (B) Microglial 
phagocytosis was assessed by the frequency of ball-and-chain phagocytic buds among Iba1+ 
cells in the dorsolateral SVZ and the CX. Individual data shown as dots, bars as mean with SD 
(error bar), n=3 animals, Two-way ANOVA with Tukey post-hoc test, * p < 0.05, ** p < 0.01, *** p 
< 0.001, **** p < 0.0001. Scale bar for (A): 10 µm. 
 
 Approximately half of the ball-and-chain phagocytosed cells were BrdU+ 
(Fig. 7A, fig. 8), indicating that they had lately been proliferating. In rare 
instances, phagocytosed cells stained for the apoptosis marker CC3, but they 
remained systematically negative for NSC / NPC markers (sex determining 
region Y-box 2 [SOX2], DCX, PAX6, polysialylated-neural cell adhesion 
molecule [PSA-NCAM], data not shown). 
 In conclusion, microglial phagocytosis was eminent in the early postnatal 
SVZ and seemed to be preserved until P40 following HI. 
 
 
   5. Results 
45 
 
Figure 8: A considerable number of ball-and-chain phagocytosed nuclei were BrdU+. The graph 
shows the frequency of phagocytic buds containing BrdU+ nuclei (green bar) among the total 
phagocytic buds (white bar, from Fig. 7) in the dorsolateral SVZ. Mean with SD (error bar), n=3 
animals. 
 
 
5.6. SVZ microglia upregulate pro- and anti-inflammatory and 
neurotrophic genes after HI 
 
 We next analyzed the transcriptome of SVZ microglia from sham or HI 
animals at P10 and P20. The dorsolateral SVZ from the ipsilateral HI or ipsi- 
and contralateral sham hemisphere was microdissected and CD11b+ microglia 
isolated with magnetic bead sorting. Flow cytometry analysis demonstrated a 
purity of > 95 % CD11b+ CD45+ cells after sorting (Fig. 9). Total RNA was 
extracted from the isolated cells (RIN ≥ 8.4 [mean 9.6]) and a total of 500 pg 
RNA per animal sample was used for microarray experiments. 
 The microarray analysis revealed high expression of microglia-specific 
transcripts, including C1qa, Cx3cr1, P2ry12 and Tmem119 among all samples, 
whereas macrophage-specific gene expression was low (Fig. 10A). The 
principal component analysis demonstrated a grouping of most samples from 
the same condition (Fig. 10B). A total of 2196 genes were significantly (FDR < 
0.05) differentially expressed between HI and sham samples at P10, with 1807 
genes up- and 389 genes downregulated. At P20, 9930 genes were 
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differentially expressed with 2642 genes up- and 7288 downregulated. Overall, 
the FC of the significantly differentially expressed genes between HI and sham 
samples were modest. At P10, 19 genes were more than two-fold upregulated 
and 3 genes downregulated, whereas at P20, 25 genes were more than two-
fold upregulated and 0 genes downregulated. 
 
Figure 9. Magnetic bead sorting resulted in a high purity of CD11b+ CD45+ microglia. 
Representative data from cortical microglia isolated by CD11b+ magnetic bead sorting. (A) 
Gating strategy for cell identification. (B) Unstained isolated cortical cells. (C) After staining with 
the corresponding antibodies, isolated cortical cells were > 95% CD11b+ CD45+. 
 
  
 
 
Figure 10. Enrichment of microglial transcripts in CD11b+ isolated SVZ cells. (A) Absolute 
expression of transcripts for microglia, macrophages, NSCs / NPCs from the SVZ niche, 
astrocytes or neurons among all samples. Mean with SD (error bar). (B) Principal component 
analysis of all samples. 
 
 The 25 most upregulated genes in ipsilateral HI SVZ microglia are listed 
in Table 2 for P10, and Table 3 for P20, respectively. Among those genes, we 
noticed a concurrent expression of both pro- and anti-inflammatory genes. Pro-
inflammatory genes that were previously reported to be expressed in microglia 
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or macrophages included RasGef1b (Andrade et al., 2010), TNFsf9 (Yeo et al., 
2012), and Rab32 (Liang et al., 2012; Haile et al., 2017) at P10, and Stat1 
(Przanowski et al., 2013), Ifi27 (Uhrin et al., 2013), or Pdpn (Kerrigan et al., 
2012) at P20. Vice-versa, anti-inflammatory genes were present, including 
Anxa2 (Zhang et al., 2015), CD206 (Casella et al., 2016), and Gpnmb (Ripoll et 
al., 2007; Chung et al., 2007) at P10, or Clec7 (Szulzewsky et al., 2015) and 
miR-146a (Saba et al., 2012) at P20. Further, P20 HI SVZ microglia 
differentially expressed antigen-presenting genes, including RT1-Da and RT1-
Ba. At both time points, microglia upregulated genes with neurotrophic effects: 
Igf-1 at P10 (Ueno et al., 2013) and C3 at P20 (Rahpeymai et al., 2006). 
 Thus, the SVZ microglia transcriptome analysis revealed a hetero-
geneous pattern of upregulated genes early after HI, including concurrent 
expression of pro- and anti-inflammatory as well as neurotrophic genes. 
 
 The microarray data were validated by qRT-PCR of additional samples 
that were not previously used in the microarray. Due to the very low 
concentration of sample RNA, validation was performed for Igf-1, which was 
significantly differentially expressed at P10, but not anymore at P20. The qRT-
PCR results of the additional samples were in line with the microarray data (Fig. 
11). 
 
Figure 11. Validation by qRT-PCR of Igf-1 microarray measurements. 
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Gene symbol Gene Name EntrezID FC HI vs. 
sham  
Emb embigin 114511 4.59 
LOC100911403 membrane-spanning 4-domains subfamily A member 4A-like 100911403 4.03 
Ms4a6c membrane-spanning 4-domains, subfamily A, member 6C 690930 2.76 
Anxa2 annexin A2 56611 2.74 
LOC290595 hypothetical gene supported by AF152002 290595 2.73 
Ms4a4a membrane-spanning 4-domains, subfamily A, member 4A 361734 2.61 
CD206 mannose receptor, C type 1 291327 2.58 
Lpl lipoprotein lipase 24539 2.48 
Ccl6 chemokine (C-C motif) ligand 6 287910 2.42 
Anxa5 annexin A5 25673 2.28 
Sdc4 syndecan 4 24771 2.24 
Stom stomatin 296655 2.19 
Rasgef1b RasGEF domain family, member 1B 100361238 2.19 
Cd8b CD8b molecule 24931 2.18 
Gpnmb glycoprotein nmb 113955 2.09 
Tnfsf9 tumor necrosis factor superfamily member 9 353218 2.09 
Atp6v1e1 ATPase H+ transporting V1 subunit E1 297566 2.06 
Rab32 RAB32, member RAS oncogene family 365042 2.05 
Mfsd1 major facilitator superfamily domain containing 1 361957 2.01 
Slirp SRA stem-loop interacting RNA binding protein 688717 1.99 
Igf-1 insulin-like growth factor 1 24482 1.99 
Pygl liver glycogen phosphorylase 64035 1.98 
Igsf6 immunoglobulin superfamily, member 6 171064 1.98 
Enpp6 ectonucleotide pyrophosphatase/phosphodiesterase 6 306460 1.95 
Tnfaip2 TNF alpha induced protein 2 299339 1.95 
Table 2: The 25 most upregulated genes in ipsilateral SVZ microglia after HI at P10 (FDR<0.05). 
 
 
Gene symbol Gene Name EntrezID FC HI vs. 
sham  
LOC100910270 uncharacterized 100910270 6.37 
Slfn4 schlafen 4 114247 4.51 
Plac8 placenta-specific 8 360914 4.12 
RT1-Da RT1 class II, locus Da 294269 3.06 
RGD1563091 similar to OEF2 500011 2.59 
Clec7a C-type lectin domain family 7, member A 502902 2.57 
Rsad2 radical S-adenosyl methionine domain containing 2 65190 2.54 
Clec12a C-type lectin domain family 12, member A 680338 2.51 
Ifi27 interferon, alpha-inducible protein 27 170512 2.45 
Tlr1 toll-like receptor 1 305354 2.26 
Pdpn podoplanin 54320 2.18 
Eif2ak2 eukaryotic translation initiation factor 2-alpha kinase 2 54287 2.17 
Stat1 signal transducer and activator of transcription 1 25124 2.17 
LOC102553917 putative zinc finger protein 724-like 102553917 2.16 
Ifi27l2b interferon, alpha-inducible protein 27 like 2B 299269 2.16 
RT1-Ba RT1 class II, locus Ba 309621 2.14 
F10 coagulation factor X 29243 2.14 
ND3 NADH dehydrogenase subunit 3 26199 2.12 
LOC100911190 probable ATP-dependent RNA helicase DDX60-like 100911190 2.11 
Oas1b 2-5 oligoadenylate synthetase 1B 246268 2.09 
C3 complement C3 24232 2.07 
LOC679827 similar to Ran-specific GTPase-activating protein 679827 2.06 
Mir146a microRNA 146a 100314241 2.06 
Cxcl17 C-X-C motif chemokine ligand 17 308436 2.05 
Mx2 MX dynamin like GTPase 2 286918 2.02 
Table 3: The 25 most upregulated genes in ipsilateral SVZ microglia after HI at P20 (FDR<0.05). 
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5.7. SVZ microglia are not polarized to M1 or M2 after HI 
 
 It is proposed that microglia are polarized to either a pro-inflammatory 
neurotoxic M1 or anti-inflammatory neuroregenerative M2 state after acute brain 
injury (Hu et al., 2015). We therefore examined whether SVZ microglia express 
markers associated with the M1 or M2 polarization state. 
 We defined gene sets for commonly used M1 or M2 polarization markers 
(Fig. 12). Most genes from both the M1 and M2 gene sets were equally 
expressed among HI and sham samples at a given time point. A 
complementary analysis with mined microarray data (Freilich et al., 2013) from 
primary cultured murine microglia exposed to LPS for M1 polarization or IL-4 for 
M2 polarization, showed similar results (Fig. 13). Thus, our analyses do not 
support that SVZ microglia were polarized to M1 or M2 after neonatal HI. 
 
 
Figure 12. SVZ microglia did not adopt a M1 or M2 phenotype after neonatal HI. Heat maps 
showing the expression of genes commonly used as M1 or M2 polarization markers in SVZ 
microglia isolated from P10 and P20 sham or HI animals. Within a polarization category, most 
genes were equally expressed among HI and sham samples, at both time points. 
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Figure 13. The SVZ microglia gene expression profile after neonatal HI did not resemble that of 
microglia exposed to LPS or IL-4. Heat maps for the 15 most differentially expressed genes in 
microglia after LPS-exposure (M1), and IL-4 exposure (M2) (from Freilich et al., 2013). As 
observed in Fig. 11, within one polarization category, most genes are equally expressed among 
HI and sham samples at P10 and P20, respectively. 
 
 
5.8. SVZ microglial transcriptome is enriched for neurodegenerative 
pathways after HI 
 
 We performed a KEGG pathway analysis of differentially expressed 
genes between HI and sham SVZ microglia (Fig. 14). In HI SVZ microglia,  the 
analysis revealed an enrichment of pathways associated with 
neurodegenerative diseases, including oxidative phosphorylation, ribosome, 
AD, Parkinson's disease, and Huntington's disease. Interestingly, these 
pathways were also enriched in recent microglial transcriptome studies in 
murine models for AD (Holtman et al., 2015) and ALS (Chiu et al., 2013). 
Holtman and colleagues (2015) performed a meta-analysis of these studies and 
identified a highly consistent consensus transcriptional profile of 295 
upregulated genes, describing a generic microglial response among the 
different disease models which is different from a LPS-stimulated response. In 
this consensus gene list, we encountered multiple genes that were among the 
most differentially expressed genes in our data set, including Anxa2, Anxa5, 
Gpnmb, Mfsd1 and Igf-1 at P10, and Clec7, Rsad2, Eif2ak2, Stat1 and C3 at 
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P20, respectively. Interestingly, when we applied this consensus profile to our 
transcriptome data, we observed a considerable number of consensus genes 
differentially upregulated in HI SVZ microglia at P10 (Fig. 15). 
 
 
Figure 14. Pathways associated with neurodegenerative diseases were enriched in SVZ 
microglia after HI at P10. KEGG-pathway analysis of differentially expressed SVZ microglial 
genes after HI for (A) P10 and (B) P20, respectively. Pathways that were most significantly 
enriched at P10, are highlighted in red. 
 
Figure. 15. The gene expression profile of SVZ microglia after neonatal HI shared similarities 
with that of microglia from rodent models of neurodegenerative diseases. Heat map for a 
consensus profile of a generic microglial response in the context of neurodegenerative diseases 
(from Holtman et al., 2015). A considerable number of consensus genes were upregulated in HI 
SVZ microglia at P10.  
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5.9. Microglial depletion reduces neurosphere formation 
 
 HI injury transiently induces the proliferation of NSC / NPC in the SVZ, 
which can be recapitulated in an in vitro neurosphere assay: neurospheres 
derived from the SVZ after HI are in higher numbers than those derived from 
sham SVZ (Buono et al., 2015). By using this in vitro model and conditional 
microglial depletion, we explored if the HI-induced effects on SVZ microglia had 
any consequences on neurosphere formation. We focused on the P10 time 
point where the HI-mediated effects on SVZ microglia were most striking. 
 Briefly, ipsi- and contralateral coronal tissue blocks that included the 
entire SVZ and medial striatum from P10 HI and sham animals were dissected 
and pooled in 3 groups: i) HI ipsi, ii) HI contra and iii) sham tissue blocks. The 
tissue blocks were dissociated to a single cell suspension and cultured for 6 
days for neurosphere formation. After seeding, cell cultures from each tissue 
group were subjected to 3 culture conditions: i) control (no depletion) ii) addition 
of IgG SAP (unspecific cell-toxic antibody) or iii) addition of anti-CD11b SAP 
(CD11b+ cell-specific toxic antibody) (Fig. 16A). 
 After 6 DIC, neurospheres were formed that expressed nestin and DCX 
as NSC and NPC markers (Fig. 16B). 
 The proportions of CD11b+ CD45+ cells were measured by flow 
cytometry before seeding and after 6 DIC (Table 4). The mean percentage of 
CD11b+ CD45+ cells before seeding was consistently higher in HI ipsi (36%) 
than in HI contra (27%) or sham tissue (23%). After 6 DIC, mean CD11b+ 
CD45+ cell proportions were similarly decreased in control and IgG SAP 
conditions in sham (relative reduction from seeding proportions by 56%) or HI 
contra (50%) but less decreased in HI ipsi (28%). Most importantly, CD11b+ 
CD45+ cells were highly reduced (98%) in the anti-CD11b culture condition 
among all tissue groups. 
 To validate these results, neurosphere cultures were stained for Iba1+ 
after 6 DIC (Fig. 16C). In all control and IgG SAP conditions, Iba1+ cells were 
abundantly attached as single cells to the bottom of the well as previously 
noticed (Deierborg et al., 2010). Interestingly, we also detected numerous Iba1+ 
cells in neurospheres, a finding which to our knowledge was previously not 
   5. Results 
53 
reported in primary neurosphere cultures. In the anti-CD11b SAP culture 
condition, Iba1+ cells were strikingly reduced and only few Iba1+ cells could be 
detected within the neurospheres. Thus, we concluded that in this culture 
condition, microglia were an inherent part of forming neurospheres and that 
their selective depletion with anti-CD11b SAP was highly effective. 
 
 
Figure 16. In vitro model to study the role of SVZ microglia in neurosphere formation. (A) 
Experimental design: neurosphere assay of primary cells from P10 animals with conditional 
depletion of microglia. (A1) Ipsi- or contralateral tissue blocks including the SVZ / medial 
striatum were separately isolated from HI animals, while ipsi- and contralateral tissue blocks 
from sham animals were pooled, resulting in 3 tissue groups (HI ipsi, HI contra and sham). (A2) 
The dissociated tissue blocks were exposed to 3 conditions, including no addition of antibodies 
(control), addition of unspecific toxic antibodies (IgG SAP), or addition of CD11b+ cell-specific 
toxic antibodies (anti-CD11b SAP) which target microglia. (B) Representative image of a 
Nestin+ DCX+ neurosphere after 6 DIC. (C) Representative images of Iba1+ cells in HI ipsi cell 
cultures after 6 DIC. The anti-CD11b SAP condition strikingly reduced Iba1+ cells. (C) 
Representative images from sham and HI ipsi cell cultures after 6 DIC. Less neurospheres were 
present in the anti-CD11b SAP conditions. Scale bar for (B): 50 µm, for (C): 100 µm, for (D): 200 
µm.  
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Before seeding Day in culture 6 Relative reduction of CD11b+ CD45+ cells from seeding to Day in culture 6 
CD11b+ CD45+ cells (%) CD11b+ CD45+ cells (%) CD11b+ CD45+ cells (%) 
Tissue 
group Condition 
Experiment 
1 
Experiment 
2 
Experiment 
3 
Experiment 
1 
Experiment 
2 
Experiment 
3 
Experiment 
1 
Experiment 
2 
Experiment 
3 Average 
Sham 
Control 
29.0 13.7 25.0 
10.5 8.1 10.1 63.8 40.9 59.6 54.8 
IgG SAP 18.9 4.9 6.9 34.8 64.2 72.4 57.2 
anti-
CD11b 
SAP 
0.2 0.2 0.4 99.3 98.5 98.4 98.8 
HI 
Contra 
Control 
41.6 16.0 24.5 
14.9 18.3 7.3 64.2 -14.4 70.2 40.0 
IgG SAP 15.1 8.6 7.8 63.7 46.3 68.2 59.4 
anti-
CD11b 
SAP 
0.5 0.3 0.6 98.8 98.1 97.6 98.2 
HI Ipsi 
Control 
42.6 31.6 34.9 
46.0 27.5 13.8 -8.0 13.0 60.5 21.8 
IgG SAP 38.8 23.3 11.2 8.9 26.3 67.9 34.4 
anti-
CD11b 
SAP 
0.9 1.4 0.7 97.9 95.6 98.0 97.2 
Table 4: Percentages of CD11b+ CD45+ cells per tissue group and condition for each 
experiment. The relative reduction of CD11b+ CD45+ cells were similar between the control and 
IgG SAP condition. However, the anti-CD11b SAP condition efficiently depleted these cells. The 
relative reduction of CD11b+ CD45+ cells was defined as the relative difference (%) between 
CD11b+ CD45+ % seeding and the CD11b+ CD45+ % Day 6. 
 
 Next, we quantified the number of neurospheres after 6 DIC (Fig. 16D, 
Fig. 17). In the control condition, the numbers of neurospheres were increased 
in HI ipsi compared to sham (HI ipsi, 2308 ± 363 vs. sham, 1714 ± 193 
neurospheres/well, p < 0.027) as shown before (Buono et al., 2015). The IgG 
SAP condition resulted in similar numbers as the control culture condition 
among all tissue groups, supporting that unspecific saporin-conjugated 
antibodies do not impair neurosphere formation. In contrast, treatment with the 
anti-CD11b SAP antibody led to a significant decrease in neurosphere numbers 
in all tissue groups, when compared to control culture conditions (p < 0.027). 
This was most prominently observed in HI ipsi. In all anti-CD11b culture 
conditions the mean number of neurospheres were in a similar range (sham, 
1203 ± 176 vs. HI contra, 1003 ± 204 vs. HI ipsi 924 ± 133). 
 We further noticed that neurospheres in the anti-CD11b condition were 
larger than neurospheres in the other culture conditions (Fig. 16D). The 
distribution of neurosphere size was similar within the same condition, 
independent of tissue origin (data not shown). However, the pooled anti-CD11b 
SAP culture conditions demonstrated an increased proportion of > 0.02 mm2 
neurospheres, when compared to the other conditions (Fig. 18).  
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 We observed a certain variance for CD11b+ CD45+ cell proportions and 
neurospheres numbers among repeated experiments. We therefore correlated 
the percentage of CD11b+ CD45+ cells and neurosphere numbers at 6 DIC. 
Interestingly, we observed a positive correlation between the two factors 
(Spearman coefficient r=0.87, 95%CI 0.68-0.93, p <0.0001, n=27). Experiments 
from different tissue groups resulted in comparable neurosphere numbers if the 
microglial proportions were similar, thus explaining the variance in repeated 
experiments (Fig. 19).  
 
Figure 17. Microglia depletion reduced the number of neurospheres in vitro. Quantification of the 
number of neurospheres after 6 DIC: In the control condition, cell cultures from HI ipsi-derived 
tissue produced more neurospheres than sham-derived, thus reflecting HI-induced 
neurogenesis. Control and IgG SAP conditions showed similar results, indicating that the 
unspecific saporin-conjugated antibodies did not interfere with overall cell growth. Most 
importantly, the exposure to anti-CD11b SAP antibodies significantly decreased neurosphere 
numbers in all tissue groups. Individual data shown as dots, bars as mean with SD (error bar), 
n=3 independent experiments, One-way ANOVA with Holm-Sidak post-hoc test, * p < 0.05, **** 
p < 0.0001.  
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Figure 18. Microglia depletion increased the proportion of very large neurospheres in vitro. 
Tissue groups treated with the same condition did not show differences in the distribution of 
neurosphere area at 6 DIC and were therefore pooled. While control and IgG SAP conditions 
resulted in similar distribution of neurosphere area, anti-CD11b SAP exposure increased the 
proportion of > 0.02 mm2 neurospheres. 
  
 
Figure 19. Positive correlation between microglial proportion and the number of neurospheres in 
vitro. The number of neurospheres increased with a higher percentage of CD11b+ CD45+ cells 
at 6 DIC, the highest values being observed in HI ipsi-derived cell cultures. 
 
 
 Overall, the cell culture experiments indicated that early postnatal 
CD11b+ CD45+ microglia supported neurosphere generation in vitro in a 
concentration-dependent manner. Culturing HI ipsi-derived tissue resulted in a 
higher number of neurospheres than sham-derived, reflecting HI-induced 
neurogenesis. Strikingly, depletion of microglia completely neutralized this 
difference and increased the proportion of very large neurospheres. Publication:  
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The data presented will be submitted for publication: 
Fisch U, Brégère C, Geier F, Chicha L, Guzman R. Characterization of rat 
subventricular zone microglia after neonatal hypoxia-ischemia. Manuscript in 
preparation, submission scheduled for June 2016.  
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6. Discussion 
 
 
 Accumulating evidence indicates that microglia in the neurogenic niches 
modulate NSC / NPC proliferation and differentiation (Sato, 2015) and are 
therefore a potential therapeutical target. Early postnatal SVZ microglia are not 
yet fully maturated (Matcovitch-Natan et al., 2016; Bennett et al., 2016) and are 
endogenously activated (Shigemoto-Mogami et al., 2014), which might affect 
their response to HI injury. To date however, most research on neonatal HI 
focused on the perilesional microglia but not on microglia in the SVZ. We 
therefore aimed to investigate the impact of neonatal HI on early postnatal SVZ 
microglia. 
 
 
6.1. Sustained accumulation and prolonged activation of SVZ microglia 
after HI 
 
 Our analysis on SVZ microglia indicated a sustained accumulation and 
prolonged activation after HI in the ipsilateral SVZ and, to a lesser extent, in the 
contralateral SVZ. The microglial accumulation occurred within 3 days after HI 
and was maintained until P40 in both ipsi- and contralateral SVZ. The proportion 
of activated microglia, defined by their expression of CD68 (Shigemoto-Mogami 
et al., 2014), was significantly increased until P20 in the ipsilateral SVZ and 
returned to sham levels at P40. In the adjacent CX and CC, HI affected 
microglial density and activation only at P10, but not afterwards. Thus, the long-
lasting SVZ microglial response to HI was unique and region-specific. 
 In a previous study, Thored and colleagues (2009) investigated the SVZ 
microglial response upon ischemic stroke in the adult rat. Their results showed 
a microglial accumulation and activation in the ipsilateral SVZ over 16 weeks 
with a peak at 6 weeks after the stroke onset. 
 There are two noteworthy differences between our study and that by 
Thored and colleagues. First, the temporal dynamics were different with a rapid 
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neonatal SVZ microglial activation to HI, which resolved within one month and in 
contrast, an adult SVZ microglial reaction that remained for more than 4 
months. Secondly, HI injury led to a reaction of SVZ microglia in the ipsilateral 
SVZ, and less extensively, also the contralateral SVZ, whereas after adult 
ischemic stroke, the contralateral SVZ microglia remained unaffected (Thored et 
al., 2009).  
 Several aspects may account for the observed differences between the 
two studies, including age, rat strains, sex distribution, cell counting 
methodology, as well as pathogenesis and severity of the injury. Notably, while 
a 2 h MCAO in the adult rat led to ipsilateral SVZ microglial accumulation 
(Thored et al., 2009), 30 min MCAO did not (Chapman et al., 2015), suggesting 
that stroke severity influences not only the neurogenic (Thored et al., 2006), but 
also the SVZ microglial response in the adult. On the other hand, we did not find 
a clear correlation between injury size and SVZ microglial accumulation or 
activation in the neonatal HI model (data not shown). Further, Thored et al. 
(2009) reported total microglial numbers, while we reported microglial density, 
which takes into account changes in SVZ size. However, we propose that the 
age difference, reflecting different microglial developmental stages between the 
early postnatal and the adult animal (Matcovitch-Natan et al., 2016, Bennett et 
al., 2016), is especially important. Interestingly, our results indicated that the 
SVZ microglial reaction was not limited to the ipsilateral, but also involved the 
contralateral SVZ, although to a lesser degree. Early postnatal microglia 
resemble rather an embryological stage before adopting an adult phenotype 
(Matcovitch-Natan et al., 2016, Bennett et al., 2016) and react more extensively, 
than their adult counterparts when directly stimulated (Denker et al., 2007; 
Christensen et al., 2014). It may be possible that the endogenous activation of 
SVZ microglia during that time period (Shigemoto-Mogami et al., 2014) render 
them exceptionally sensitive to remote tissue damage. Importantly, our 
histological analyses did not suggest that such a potential increased sensitivity 
would permanently affect the SVZ microglia. On the contrary, the fact that their 
response upon HI injury appeared to resolve faster than what was observed 
after adult ischemic stroke, suggests that either intrinsic or extrinsic factors in 
early postnatal SVZ microglia favour a recovery. 
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6.2. Early SVZ microglial proliferation is increased by HI 
 
 BrdU-labelling in the dorsolateral sham SVZ indicated a noticeable 
microglial proliferation at P10 but not afterwards. Neonatal HI injury potentiated 
this proliferation in both the ipsi- and contralateral SVZ at P10, but did not 
induce proliferation thereafter. However, our results did not indicate if this early 
microglial proliferation was sufficient for the long-standing cell accumulation or if 
it was partially caused by additional migrating microglia / macrophages. The 
latter possibility remains unanswered, as current IHC techniques cannot 
specifically differentiate rat microglia from macrophages. It was previously 
proposed that periventricular microglia in the early postnatal brain are mainly 
derived from migrating macrophages (Ling and Wong, 1993), and it is 
conceivable that monocytes transmigrate to the brain after HI via the highly 
vascularized SVZ. On the other hand, CD11b+ cells isolated from the SVZ at 
P10 and P20 highly expressed typical microglial genes, thus a significant 
contribution of macrophages is therefore less likely. 
 
 
6.3. SVZ microglia remain phagocytic after HI 
 
 Microglial phagocytosis is fundamental for CNS development and 
maintenance, immune defense, and tissue repair (Sierra et al., 2013; Neumann 
et al., 2009). SVZ microglia regulate the number of cortical neurons by 
phagocytosing NPCs during embryogenesis (Cunningham et al., 2013). 
Postnatally, microglia maintain tissue homeostasis by phagocytosing apoptotic 
NPCs in the SVZ and the SGZ via ball-and-chain shaped engulfing buds (Sierra 
et al., 2010; Fourgeaud et al., 2016; Frost and Schafer, 2016). Early postnatal 
periventricular microglia are highly phagocytic (Ling and Wong, 1993; Hristova 
et al., 2010) and gradually change from an amoeboid to a ramified morphology. 
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 In this study, we assessed the morphology and the number of ball-and-
chain phagocytic buds in relation to microglial numbers in the dorsolateral SVZ. 
In sham animals, the proportion of amoeboid microglia decreased continuously 
with age. However, HI injury temporarily increased the proportion of amoeboid 
microglia in both ipsi- and contralateral SVZ at P10. 
 While the relative number of ball-and-chain phagocytic buds continuously 
decreased among sham SVZ microglia, it contrariwise increased in HI animals. 
These results have important limitations. Ball-and-chain phagocytic buds are 
best observed in ramified microglia which must be considered when interpreting 
the countings in P10 HI SVZ microglia where only a minority of cells were 
ramified. Further, few studies have so far quantified microglial phagocytosis in 
vivo (Sierra et al., 2013) and ball-and-chain buds may represent only one of 
several forms of microglial phagocytosis. Microglial phagocytosis is a fast 
process and completed in less than 30 min (Morsch et al., 2015). Thus, our 
results from fixed tissue represented a snapshot and could only approximate 
phagocytic activity in vivo. Despite these limitations, our data clearly indicated 
marked differences in ball-and-chain-type phagocytosis between HI and sham 
SVZ microglia at P40 when both HI and sham SVZ microglia were ramified. 
 In this study, phagocytosed cells very rarely stained for the apoptotic 
marker CC3. As it is suggested that microglia can also phagocytose live cells 
(Brown and Neher, 2014), it is conceivable that SVZ microglia preferentially 
phagocytose live NSCs / NPCs. It is noteworthy that, roughly half of the 
engulfed cells were BrdU+, indicating that they were proliferating within 3 days 
before sacrifice. However, the engulfed cells did not stain for NSC / NPC 
markers, including SOX2, PAX6, PSA-NCAM and DCX. Thus the identity of 
these cells remained unknown. In a previous study in the adult hippocampus, 
cells engulfed by microglia stained positively for PSA-NCAM, but not DCX. A 
different degradation rate of those proteins was suggested to be responsible for 
this discrepancy (Sierra et al., 2010). Similarly, in the early postnatal SVZ, a 
rapid protein degradation by microglia could be a potential reason for the 
systematic negative stainings for NSC / NPC markers. 
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6.4. SVZ microglia express neurotrophic and immunomodulatory genes 
early after HI 
 
 We performed a microarray transcriptome analysis of purified CD11b+ 
SVZ microglia from individual sham and HI animals. The results indicated a high 
enrichment of microglial, but not macrophage-specific genes. Of note, we also 
noticed an elevated gene expression of NSC / NPC markers, such as Dcx. Flow 
cytometry analysis indicated a > 95 % purity of CD11b+ isolated cells and 
therefore it is possible that NSC / NPC transcripts originated from the 5 % 
CD11b- cells. Another potential explanation comes from a study by Solga and 
colleagues (2015). These authors found neuronal and oligodendroglial 
transcripts, but not proteins, in brainstem microglia and hypothesized that the 
presence of these mRNAs may reflect microglial RNA uptake from their 
surroundings. Likewise, NSC / NPC transcripts in SVZ microglia might also 
reflect an analog RNA uptake.  
 HI induced both pro- and anti-inflammatory genes, illustrating the 
complexity of the SVZ microglial reaction. Of note, IL-1β, IL-6, TNF-ɑ and IFN-γ, 
which are strongly upregulated in acute inflammation (Monje et al., 2003; 
Butovsky et al., 2006, Cacci et al., 2008) were not differently expressed 
between HI and sham SVZ microglia (data not shown), underscoring that the 
SVZ microglia were not directly affected by the HI injury.  
 Among the 25 most upregulated genes in P10 ipsilateral SVZ microglia, 
we noted IGF-1 and Gpnmb. IGF-1 is a well-known neurotrophic factor that can 
affect NPCs in multiple ways, including anti-apoptotic effects (Chrysis et al., 
2012), reduction of cell cycle length and increase of cell cycle reentry (Hodge et 
al., 2004). SVZ and striatal microglia upregulate IGF-1 after ischemic stroke in 
the rat (Thored et al., 2009; Chapman et al., 2015). Microglial IGF-1 production 
is essential for cortical neuronal survival (Ueno et al., 2013) and is 
neuroprotective after ischemic stroke (Lalancette-Hébert et al., 2007). 
 In the rodent brain, Gpnmb is predominantly expressed by microglia 
(Huang et al., 2012). It is found to be upregulated by microglia after systemic 
LPS exposure (Huang et al., 2012), in a model of AD  (Kamphuis et al., 2016), 
and in the context of glioma (Szulzewsky et al., 2015). The perilesional brain 
   6. Discussion 
63 
tissue after ischemia and the retina after optic nerve transection also 
demonstrate an increased expression of Gpnmb (Buga et al., 2012; Nakano et 
al., 2014, Yasuda et al., 2016). In murine macrophages, Gpnmb attenuates the 
inflammatory response upon LPS or IFN-γ stimulation (Ripoll et al., 2007) and 
negatively regulates T-cell activation (Chung et al., 2007). Furthermore, Gpnmb 
is associated with neuroprotective effects in murine models for brain ischemia 
(Nakano et al., 2014) and ALS (Tanaka et al., 2012). Thus, the SVZ microglia 
transcriptome reflects a heterogeneous response to neonatal HI with 
neurotrophic Igf-1 and immunomodulatory Gpnmb among the most upregulated 
genes at P10. 
 
 
6.5. SVZ microglia do not adopt a M1 or M2 polarization after HI 
 
 The concept of microglial polarization originated from in vitro 
observations in macrophages. Upon activation, microglia are thought to adopt a 
pro-inflammatory neurotoxic M1 or anti-inflammatory neuroregenerative M2 
state (Hu et al., 2015). Although this concept is widely used for microglial 
phenotype characterization, recent in vivo transcriptome studies demonstrate 
that activated microglia / macrophages simultaneously co-express M1 / M2 
polarization genes rather than displaying a relevant tendency toward either a 
M1 or M2 phenotype (Chiu et al., 2013; Holtman et al., 2015; Szulzewsky et al., 
2015; Morganti et al., 2016; Kim et al., 2016; Ransohoff, 2016). We explored if 
SVZ microglia adopt a M1 or M2 state after HI injury with two independent gene 
sets from commonly used polarization markers an from an in vitro polarized 
microglial transcriptome analysis (Freilich et al., 2013). Overall, these analyses 
did not indicate a clear tendency of SVZ microglia adopting either a M1 or M2 
state after HI, although individual M1 / M2 markers (e.g. CD206 for M2 at P10, 
Stat1 for M1 at P20) were found among the most upregulated genes. On the 
contrary, the data rather suggested a moderate upregulation of both M1 / M2 
markers with age that was independent of HI or sham surgery. 
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6.6. SVZ microglia transiently upregulate neurodegeneration-associated 
genes after HI 
 
 The KEGG pathway analysis of differentially expressed genes in P10 HI 
SVZ microglia showed an enrichment of pathways that are associated with 
neurodegenerative diseases. Interestingly, similar pathways were enriched in 
isolated microglia in a transgenic ALS model. In this model, microglia 
concurrently upregulated neurotoxic and neurotrophic genes which were distinct 
from genes upregulated after LPS-exposure. Strikingly, the microglial genes 
which were most upregulated in the ALS model and in parallel downregulated 
after LPS-exposure were Igf-1 and Gpnmb (Chiu et al., 2013). These two genes 
are also found among the most upregulated genes in SVZ microglia after HI at 
P10. Igf-1 and Gpnmb were also distinctively upregulated in other microglial 
transcriptome studies in animal models for AD, accelerated aging, and 
physiological aging (Srinivasan et al., 2016, Holtman et al., 2015). Holtman and 
colleagues (2015) identified a gene set, including Igf-1 and Gpnmb, which was 
highly consistent among microglia in these animal models of neurodegenerative 
diseases. When applying this consensus gene set to our transcriptome data, we 
observed a considerable number of genes upregulated in HI SVZ microglia at 
P10. This was unexpected given the different pathogenesis of HI injury and 
neurodegenerative diseases like AD and ALS. There are multiple differences 
between our and the aforementioned transcriptome studies, including species, 
age, microglia isolation protocols and gene expression profiling methods, which 
can act as potential confounding factors. Nevertheless, the shared gene 
expression pattern is remarkable and merits further investigation. At this stage, 
we would like to refrain from characterizing the SVZ microglia after neonatal HI 
as “neurodegenerative-like”. Rather, our data show that the generic microglial 
response pattern observed in different neurodegenerative diseases (Holtman et 
al., 2015, Colonna and Butovsky, 2017) may actually be shared by radically 
distinct CNS pathologies. 
 Altogether, the gene expression induction of SVZ microglia upon HI is 
complex and beyond a simplified categorization into a pro- or anti-inflammatory 
response. The comparison with recent microglial transcriptome studies in 
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models of neurodegenerative diseases revealed a marked overlap of 
upregulated genes which potentially indicates a generic microglial response to 
various pathologies (Chiu et al., 2013; Holtman et al., 2015). 
 
 
6.7. SVZ microglia support neurosphere generation in vitro 
 
 The HI-induced proliferation of NSCs / NPCs in the SVZ can be 
recapitulated in an in vitro neurosphere assay (Buono et al., 2015). By using this 
neurosphere assay and specific depletion of microglia, we explored if the HI-
induced effects on SVZ microglia had any consequences on neurosphere 
generation. For these in vitro experiments, we focused on P10 SVZ microglia 
since the HI-mediated effects were the strongest at this time point. Our analyses 
showed that microglia were not only present as single cells at the bottom of the 
cell culture well (Deierborg et al., 2010), but also within the neurospheres. As 
previously reported, the number of neurospheres derived from the ipsilateral HI 
SVZ were significantly increased than that derived from sham SVZ (Buono et 
al., 2015). However, this HI-enhanced proliferation was completely neutralized 
when microglia were depleted. The microglial percentage and the neurosphere 
numbers positively correlated among all conditions, suggesting that microglia 
supported neurosphere formation in a concentration-dependent manner. 
 These findings are in line with several previous in vitro studies, which 
demonstrated microglial support of NPC and neurosphere proliferation. 
Conditioned medium from mixed cell cultures containing microglia from young 
(Walton et al., 2006) or ischemic rodent brain tissue (Deierborg et al., 2010) 
promoted NPC proliferation. In a co-culture system, human microglia had 
inhibiting effects on NPC differentiation (Liu et al., 2013). The inhibiting effects 
of LPS and IFN-γ on murine neurosphere formation was attenuated by the 
presence of microglia (Li et al., 2010, Ortega et al., 2014). Finally, IL-6, most 
likely derived from microglia, promoted neurosphere proliferation within the first 
48 h after neonatal HI in rats (Covey et al., 2011). 
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 In accordance with the findings by Covey and colleagues (2011), the  
SVZ microglia transcriptome data showed no difference in IL-6 gene expression 
between HI and sham animals at 3 days after the injury. Furthermore, IL-1β, 
TNF-ɑ and IFN-γ, which modulate neurogenesis and oligodendrogenesis in vitro 
(Shigemoto-Mogami et al., 2014), were not differently expressed among HI and 
sham animals. However, early postnatal SVZ microglia highly expressed IGF-1 
(Shigemoto-Mogami et al., 2014), which we found to be upregulated after HI. 
IGF-1 was shown to stimulate neurosphere proliferation in vitro (Erickson et al., 
2008; Supeno et al., 2013) and neuronal survival in vivo (Ueno et al., 2013). 
Future studies are warranted to identify the SVZ microglial mediators which 
enhance neurosphere formation after HI. 
 SVZ-derived NPCs were recently shown to establish functional gap 
junctions with microglia (Talaveron et al., 2015). Our in vitro experiments 
showed that microglia were an integral part of neurospheres. Hence, it is 
conceivable that microglia may modulate NPC not only via secreted factors but 
also through direct cell-cell-interaction. Importantly, microglial interaction with 
NPCs is reciprocal with NPCs enhancing microglial proliferation (Mosher et al., 
2012; Liu et al., 2013), which is underlined by our results, where microglial 
proportions positively correlated with neurosphere numbers with highest values 
in cultures from the ipsilateral HI SVZ. 
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7. Conclusions 
 
 Our report provides the first in depth characterization of the microglial 
phenotype in the rat SVZ after neonatal HI. Microglia are an inherent cellular 
component of the early postnatal SVZ and undergo specific developmental 
changes that are disrupted by neonatal HI injury. The SVZ microglial response 
upon HI, manifested by cellular accumulation, prolonged activation and 
phagocytosis, is SVZ-specific and does not occur in adjacent brain regions. 
Nevertheless, the SVZ microglial response is not permanent and resolves faster 
than what is observed in rodent models of adult stroke. SVZ microglia are 
sensitive to remote HI  injury and upregulate both pro- and anti-inflammatory 
genes and do not adopt a M1 or M2 polarized state,  but instead share to a 
certain degree a gene expression pattern with microglia in models of 
neurodegenerative diseases. In vitro, early postnatal microglia appear to show 
trophic support for neurosphere generation in a concentration dependent 
manner. 
 
 The microglial reaction upon imbalances in the CNS is context-
dependent. Concurrent positive and negative effects on CNS regeneration 
makes the microglial response a complex subject to characterize. Accumulating 
evidence indicates that the microenvironment and the temporal dynamics of the 
microglial reaction are essential factors which need to be considered when 
characterizing the microglial phenotype after brain injury. Hence, we specifically 
focused our studies on microglia in the SVZ at acute, subacute and chronic 
stages after neonatal HI. 
 Our findings contribute to a better understanding of the diverse microglial 
roles in different CNS regions and give insight into the microglial responses 
upon remote brain injury. A major result of this study is that early postnatal SVZ 
microglia are sensitive to distant HI injury and show a prolonged subacute 
response when compared to their counterparts in adjacent brain regions. Such 
findings are potentially important when considering microglia as a therapeutic 
target after brain injury. Although currently unavailable (Hagberg et al., 2015), a 
specific pharmacological modulation of microglia upon injury will likely 
systemically affect microglia. It is therefore crucial to first obtain a fundamental 
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understanding of microglial responses in specific brain regions, including the 
SVZ, in order to estimate consequences of such potential treatments for the 
whole CNS. 
 
 Microglia in the SVZ are increasingly recognized as modulators of 
neurogenesis (Sato, 2015). Our descriptive in vivo studies did not demonstrate 
direct evidence that SVZ microglia are required for the HI-induced increase in 
SVZ neurogenesis. One possibility to further approach this question would be a 
selective depletion of SVZ microglia before neonatal HI. However, depletion 
options in the rat are limited. Reduction of SVZ microglia in the adult rat by 
saporin-conjugated antibodies were insufficient (Heldmann et al., 2011). While 
depletion of perilesional microglia via uptake of clodronate liposomes was 
successful in the rat neonate after MCAO (Faustino et al., 2011), its specificity 
in the SVZ must be carefully evaluated since SVZ NPCs also avidly engulf 
liposomes (Lu et al., 2011). We therefore consider a transgenic mouse model 
for conditional microglial depletion as more suitable to address this question. 
Furthermore, transgenic mouse models offer the advantage to differentiate 
microglia from macrophages that may play a different role in SVZ neurogenesis. 
 Although our in vivo studies did not show direct evidence for SVZ 
microglia significantly enhancing neurogenesis after HI, the results did not 
suggest a detrimental effect either. The microglial upregulation of neurotrophic 
and immunomodulatory genes after HI as well as the trophic support of 
microglia on neurosphere generation are a promising basis for further research. 
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AD Alzheimer's disease 
ALS Amyotrophic lateral 
sclerosis 
Arg1 Arginase-1 
BBB Blood-brain-barrier 
BDNF Brain-derived neurotrophic 
factor 
BM Bone marrow 
BRDU Bromodeoxyuridine 
CAA Common carotid artery 
CC Median corpus callosum 
CC3 Cleaved-caspase-3 
CI 95% confidence interval 
CNS Central nervous system 
CSF1R  Colony stimulating factor 1 
receptor 
CR3 Complement receptor 3 
CX M2 supplementary motor 
cortex 
CX3CL1 Fractalkine 
CX3CR1 Fractalkine receptor 
DAP12 TYRO protein tyrosine 
kinase-binding protein 
DIC Days in culture 
E Embryonic day 
EDTA Ethylene-
diaminetetraacetic acid 
EGF Epidermal growth factor 
FC Fold-change 
FDR False discovery rate 
FGF Fibroblast growth factor 
HBSS Hank's balanced salt 
solution 
HI Hypoxia-ischemia 
HIE Hypoxic-ischemic 
encephalopathy 
Iba1 Ionized calcium-binding 
adapter molecule 1 
iDTR Inducible diphtheria toxin 
receptor 
iNOS  Inducible nitric oxidase 
IFN-γ Interferon-γ 
IGF-1 Insulin growth factor-1 
IHC Immunohistochemical 
IL Interleukin 
KEGG Kyoto Encyclopedia of 
Genes and Genomes 
LPS Lipopolysaccharide 
MCAO Middle cerebral artery 
occlusion 
NADPH Nicotinamide adenine 
dinucleotide phosphate 
NPC Neural progenitor cell 
NSC Neural stem cell 
P Postnatal day 
PAX6 Paired box 6 protein 
PB Phosphate buffer 
PBS Phosphate-buffered saline 
PCNA Proliferating cell nuclear 
antigen 
PFA Paraformaldehyde 
PSA-NCAM Polysialylated-neural cell 
adhesion molecule 
qRT-PCR  Quantitative real-time 
polymerase chain reaction 
RT Room temperature 
SD Standard deviation 
SGZ Subgranular zone 
SOX2 Sex determining region Y-
box 2 
SVZ  Subventricular zone 
TBS Tris-buffered saline 
TGF-β  Transforming growth 
factor-β 
TMEM119 Transmembrane protein 
119 
TNF-ɑ Tumor necrosis factor-ɑ 
TUJ1 Neuron-specific class III β -
tubulin 
TREM-2 Triggering receptor 
expressed on myeloid 
cells-2 
VEGF  Vascular endothelial 
growth factor 
 
 
 
 
